þ
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
FOR THE FISCAL YEAR ENDED DECEMBER 31, 2006 | ||
OR | ||
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934 |
Delaware | 98-0420726 | |
(State or Other Jurisdiction
of
Incorporation or Organization) |
(I.R.S. Employer
Identification No.) |
|
1601 West LBJ Freeway, Dallas, TX | 75234-6034 | |
(Address of Principal Executive Offices) | (Zip Code) |
Name of Each Exchange
|
||
Title of Each Class
|
on Which Registered
|
|
Series A Common Stock, par value $0.0001 per share | New York Stock Exchange | |
4.25% Convertible
Perpetual Preferred Stock, par
value $0.01 per share (liquidation preference $25.00 per share) |
New York Stock Exchange |
2
Item 1. | Business |
3
4
Technical
|
Performance
|
|||||||
Chemical Products | Polymers Ticona | Acetate Products | Products | |||||
2006 Net Sales(1)
Key Products |
$4,608 million
Acetic acid VAM Polyvinyl alcohol (PVOH) Emulsions Acetic anhydride Acetate esters Carboxylic acids Methanol Oxo Alcohols Amines Polyvinyl Acetate |
$915 million
POM UHMW-PE (GUR)
Liquid crystal
polymers (Vectra)
Polyphenylene sulfide
(PPS) (Fortron)
Polyester Engineering Resins
Long Fiber reinforced
thermoplastics |
$700 million
Acetate tow |
$176 million
Sunett ® sweetener Sorbates |
||||
Major End-Use Markets
|
Paints
Coatings Adhesives Lubricants Detergents Pharmaceuticals Films Textiles Inks Plasticizers Esters Solvents Glass Fibers Building products |
Fuel system components
Conveyor belts
Battery Separators Electronics Seat belt mechanisms
Other Automotive
Appliances and Electronics
Filtrations
Coatings Medical Telecommunications |
Filter products |
Beverages
Confections Baked goods Pharmaceuticals |
(1) | Consolidated net sales of $6,656 million for the year ended December 31, 2006 also include $257 million in net sales from Other Activities, primarily attributable to our captive insurance companies and our AT Plastics business. Chemical Products net sales exclude inter-segment sales of $134 million for the year ended December 31, 2006. |
5
6
7
| Acetic acid, used to manufacture VAM, other acetyl derivatives and other end uses, including purified terephthalic acid (PTA). We manufacture acetic acid for our own use, as well as for sale to third parties, including other participants in the acetyl derivatives business; | |
| VAM, used in a variety of adhesives, paints, films, coatings and textiles. We manufacture VAM for our own use, as well as for sale to third parties; | |
| Methanol, principally sold to the merchant market; | |
| Acetic anhydride, a raw material used in the production of cellulose acetate, detergents and pharmaceuticals; and | |
| Acetaldehyde, a major feedstock for the production of polyols. Acetaldehyde is also used in other organic compounds such as pyridines, which are used in agricultural products. |
8
| Ethyl acetate, an acetate ester that is a solvent used in coatings, inks and adhesives and in the manufacture of photographic films and coated papers; | |
| Butyl acetate, an acetate ester that is a solvent used in inks, pharmaceuticals and perfume; | |
| Propyl acetate, an acetate ester that is a solvent used in inks, lacquers and plastics; | |
| Methyl ethyl ketone, a solvent used in the production of printing inks and magnetic tapes; | |
| Butyric acid, an intermediate for the production of esters used in artificial flavors; | |
| Propionic acid, an organic acid used to protect and preserve grain; and | |
| Formic acid, an organic acid used in textile dyeing and leather tanning. |
| Formaldehyde, primarily used to produce adhesive resins for plywood, particle board, POM engineering resins and a compound used in making polyurethane; | |
| Polyol products such as trimethylolpropane, used in synthetic lubricants; neopentyl glycol, used in powder coatings; and 1,3-butylene glycol, used in flavorings and plasticizers. |
| Butanol, used as a solvent for lacquers, dopes and thinners, and as an intermediate in the manufacture of chemicals, such as butyl acrylate; | |
| Propanol, used as an intermediate in the production of amines for agricultural chemicals, and as a solvent for inks, resins, insecticides and waxes. |
| Carboxylic acids such as pelargonic acid, used in detergents and synthetic lubricants, and heptanoic acid, used in plasticizers and synthetic lubricants; | |
| Amines such as methyl amines, used in agrochemicals, monoisopropynol amines, used in herbicides, and butyl amines, used in the treatment of rubber and in water treatment; and |
9
| Oxo derivatives and special solvents, such as crotonaldehyde, which is used by the Performance Products segment for the production of sorbates, as well as raw materials for the fragrance and food ingredients industry. |
Successor | Predecessor | ||||||||||||||||||||||||||||||||
Year Ended
|
Year Ended
|
Nine Months Ended
|
Three Months Ended
|
||||||||||||||||||||||||||||||
December 31,
|
December 31,
|
December 31,
|
March 31,
|
||||||||||||||||||||||||||||||
2006 | 2005 | 2004 | 2004 | ||||||||||||||||||||||||||||||
% of
|
% of
|
% of
|
% of
|
||||||||||||||||||||||||||||||
$ | Segment | $ | Segment | $ | Segment | $ | Segment | ||||||||||||||||||||||||||
(In millions) | |||||||||||||||||||||||||||||||||
North America
|
1,630 | 35 | % | 1,570 | 38 | % | 923 | 37 | % | 297 | 38% | ||||||||||||||||||||||
Europe/Africa
|
1,931 | 42 | % | 1,625 | 39 | % | 965 | 39 | % | 314 | 40% | ||||||||||||||||||||||
Asia/Australia
|
864 | 19 | % | 809 | 19 | % | 484 | 20 | % | 144 | 19% | ||||||||||||||||||||||
Rest of World
|
183 | 4 | % | 159 | 4 | % | 93 | 4 | % | 25 | 3% | ||||||||||||||||||||||
|
10
11
12
Successor | Predecessor | ||||||||||||||||||||||||||||||||
Nine Months
|
Three Months
|
||||||||||||||||||||||||||||||||
Year Ended
|
Year Ended
|
Ended
|
Ended
|
||||||||||||||||||||||||||||||
December 31,
|
December 31,
|
December 31,
|
March 31,
|
||||||||||||||||||||||||||||||
2006 | 2005 | 2004 | 2004 | ||||||||||||||||||||||||||||||
% of
|
% of
|
% of
|
% of
|
||||||||||||||||||||||||||||||
$ | Segment | $ | Segment | $ | Segment | $ | Segment | ||||||||||||||||||||||||||
(In millions) | |||||||||||||||||||||||||||||||||
North America
|
311 | 34% | 339 | 38% | 247 | 39% | 95 | 42% | |||||||||||||||||||||||||
Europe/Africa
|
500 | 55% | 465 | 53% | 331 | 52% | 116 | 51% | |||||||||||||||||||||||||
Asia/Australia
|
55 | 6% | 44 | 5% | 33 | 5% | 9 | 4% | |||||||||||||||||||||||||
Rest of World
|
49 | 5% | 39 | 4% | 25 | 4% | 7 | 3% | |||||||||||||||||||||||||
|
13
Successor | Predecessor | ||||||||||||||||||||||||||||||||
Year Ended
|
Year Ended
|
Nine Months Ended
|
Three Months Ended
|
||||||||||||||||||||||||||||||
December 31,
|
December 31,
|
December 31,
|
March 31,
|
||||||||||||||||||||||||||||||
2006 | 2005 | 2004 | 2004 | ||||||||||||||||||||||||||||||
% of
|
% of
|
% of
|
% of
|
||||||||||||||||||||||||||||||
$ | Segment | $ | Segment | $ | Segment | $ | Segment | ||||||||||||||||||||||||||
(In millions) | |||||||||||||||||||||||||||||||||
North America
|
127 | 18% | 126 | 19% | 67 | 15% | 24 | 17% | |||||||||||||||||||||||||
Europe/Africa
|
184 | 26% | 202 | 31% | 139 | 32% | 43 | 29% | |||||||||||||||||||||||||
Asia/Australia
|
370 | 53% | 315 | 48% | 222 | 50% | 75 | 51% | |||||||||||||||||||||||||
Rest of World
|
19 | 3% | 16 | 2% | 13 | 3% | 5 | 3% | |||||||||||||||||||||||||
|
14
15
Successor | Predecessor | ||||||||||||||||||||||||||||||||
Nine Months
|
Three Months
|
||||||||||||||||||||||||||||||||
Year Ended
|
Year Ended
|
Ended
|
Ended
|
||||||||||||||||||||||||||||||
December 31,
|
December 31,
|
December 31,
|
March 31,
|
||||||||||||||||||||||||||||||
2006 | 2005 | 2004 | 2004 | ||||||||||||||||||||||||||||||
% of
|
% of
|
% of
|
% of
|
||||||||||||||||||||||||||||||
$ | Segment | $ | Segment | $ | Segment | $ | Segment | ||||||||||||||||||||||||||
(In millions) | |||||||||||||||||||||||||||||||||
North America
|
73 | 42% | 58 | 32% | 52 | 40% | 19 | 43% | |||||||||||||||||||||||||
Europe/Africa
|
64 | 36% | 80 | 44% | 49 | 37% | 17 | 39% | |||||||||||||||||||||||||
Asia/Australia
|
25 | 14% | 30 | 17% | 21 | 16% | 6 | 14% | |||||||||||||||||||||||||
Rest of World
|
14 | 8% | 12 | 7% | 9 | 7% | 2 | 4% | |||||||||||||||||||||||||
|
16
Name
|
Location
|
Ownership |
Segment
|
Partner(s)
|
Year Entered | |||||||||
Equity Investments
|
||||||||||||||
European Oxo GmbH
|
Germany | 50% | Chemical Products | Degussa AG | 2003 | |||||||||
KEPCO
|
South Korea | 50% | Ticona | Mitsubishi Gas Chemical Company, Inc. | 1999 | |||||||||
Polyplastics Co., Ltd.
|
Japan | 45% | Ticona | Daicel Chemical Industries Ltd. | 1964 | |||||||||
Fortron Industries LLC
|
U.S. | 50% | Ticona | Kureha Corporation | 1992 | |||||||||
Cost Investments
|
||||||||||||||
National Methanol Co.
|
Saudi Arabia | 25% | Chemical Products |
Saudi Basic Industries Corporation
(SABIC)/
CTE Petrochemicals |
1981 | |||||||||
Kunming Cellulose Fibers Co.
Ltd.
|
China | 30% | Acetate Products |
China National
Tobacco Corp. |
1993 | |||||||||
Nantong Cellulose Fibers Co.
Ltd.
|
China | 31% | Acetate Products |
China National
Tobacco Corp. |
1986 | |||||||||
Zhuhai Cellulose Fibers
Co. Ltd.
|
China | 30% | Acetate Products |
China National
Tobacco Corp. |
1993 |
17
18
Employees as of December 31, | ||||||||||||
2006 | 2005 | 2004 | ||||||||||
North America
|
4,700 | 4,900 | 5,500 | |||||||||
thereof USA
|
3,300 | 3,500 | 4,000 | |||||||||
thereof Canada
|
500 | 600 | 400 | |||||||||
thereof Mexico
|
900 | 800 | 1,100 | |||||||||
Europe
|
3,900 | 4,100 | 3,300 | |||||||||
thereof Germany
|
2,600 | 2,800 | 3,000 | |||||||||
Asia
|
250 | 200 | 200 | |||||||||
Rest of World
|
50 | 100 | 100 | |||||||||
Total Employees
|
8,900 | 9,300 | 9,100 | |||||||||
19
Item 1A. | Risk Factors |
20
| Shortages of raw materials due to increasing demand, e.g., from growing uses or new uses; | |
| Capacity constraints, e.g., due to construction delays, strike action or involuntary shutdowns; | |
| The general level of business and economic activity; and | |
| The direct or indirect effect of governmental regulation. |
21
22
23
| CAG will indemnify Hoechst for the total amount of these liabilities up to 250 million; | |
| Hoechst will bear the full amount of those liabilities between 250 million and 750 million; and | |
| CAG will indemnify Hoechst for one third of those liabilities for amounts exceeding 750 million. |
24
25
26
| making it more difficult for us to make payments on our debt; | |
| increasing vulnerability to general economic and industry conditions; | |
| requiring a substantial portion of cash flow from operations to be dedicated to the payment of principal and interest on indebtedness, therefore reducing our ability to use our cash flow to fund operations, capital expenditures and future business opportunities; | |
| exposing us to the risk of increased interest rates as certain of our borrowings, primarily the borrowings under the amended and restated senior credit facilities, are at variable rates of interest; | |
| limiting our ability to obtain additional financing for working capital, capital expenditures, product development, debt service requirements, acquisitions and general corporate or other purposes; and | |
| limiting our ability to adjust to changing market conditions and placing us at a competitive disadvantage compared to our competitors who have less debt. |
27
28
Item 1B. | Unresolved Staff Comments |
Item 2. | Properties |
Site
|
Leased/Owned
|
Products/Functions
|
||
Corporate Offices
|
||||
Dallas, Texas, USA
|
Leased | Corporate headquarters | ||
Kronberg/Taunus, Germany
|
Leased | Administrative offices | ||
Chemical Products
|
||||
Bay City, Texas, USA
|
Owned | Butyl acetate, Iso-butylacetate, Propylacetate, VAM, Carboxylic acids, n/i-Butyraldehyde, Butyl alcohols, Propionaldehyde, Propyl alcohol | ||
Bishop, Texas, USA
|
Owned | Formaldehyde, Methanol, Pentaerythritol, Polyols | ||
Boucherville, Quebec, Canada
|
Owned | Conventional emulsions | ||
Calvert City, Kentucky, USA
|
Leased | PVOH | ||
Cangrejera, Veracruz, Mexico
|
Owned | Acetic anhydride, Acetone derivatives, Ethyl acetate, VAM, Methyl amines | ||
Clear Lake, Texas, USA
|
Owned | Acetic acid, VAM | ||
Edmonton, Alberta, Canada
|
Owned | Methanol | ||
Enoree, South Carolina, USA
|
Owned | Conventional emulsions, Vinyl acetate ethylene emulsions | ||
Frankfurt am Main, Germany
|
Owned by InfraServ GmbH & Co. Hoechst KG, in which CAG holds a 31.2% limited partnership interest | Acetaldehyde, Butyl acetate Conventional emulsions,Vinyl acetate ethylene emulsions, VAM | ||
Geleen, Netherlands
|
Owned | Vinyl acetate ethylene emulsions | ||
Guardo, Spain
|
Owned | PVOH, Polyvinyl acetate | ||
Meredosia, Illinois, USA
|
Owned | Vinyl acetate ethylene emulsions, Conventional emulsions | ||
Nanjing, China
|
Leased | Acetic acid, Acetic anhydride | ||
Oberhausen, Germany
|
Owned by InfraServ GmbH & Co. Oberhausen KG, in which CAG holds an 84.0% limited partnership interest | Amines, Carboxylic acids, Neopentyl glycols | ||
Pampa, Texas, USA
|
Owned | Acetic acid, Acetic anhydride, Ethyl acetate | ||
Pardies, France
|
Owned | Acetic acid, VAM |
29
Site
|
Leased/Owned
|
Products/Functions
|
||
Roussillon, France
|
Leased | Acetic anhydride, Polyvinyl acetate | ||
Pasadena, Texas, USA
|
Leased | PVOH | ||
Jurong Island, Singapore
|
Owned | Acetic acid, Butyl acetate, Ethyl acetate, VAM | ||
Koper, Slovenia
|
Owned | Conventional emulsions | ||
Shanghai, China
|
Leased | Acetic acid | ||
Tarragona, Spain
|
Owned by Complejo Industrial Taqsa AIE, in which CAG holds a 15.0% share | Vinyl acetate monomer, Vinyl acetate ethylene emulsions, Conventional emulsions | ||
Tarragona, Spain
|
Owned | PVOH | ||
Perstorp, Sweden
|
Owned | Conventional emulsions, Vinyl acetate ethylene emulsions | ||
Warrington, UK
|
Owned | Conventional emulsions, Vinyl acetate ethylene emulsions | ||
Acetate Products
|
||||
Edmonton, Alberta, Canada(1)
|
Owned | Flake | ||
Lanaken, Belgium
|
Owned | Tow | ||
Little Heath, Coventry, UK(2)
|
Leased | Tow | ||
Narrows, Virginia, USA
|
Owned | Tow, Flake | ||
Ocotlán, Jalisco, Mexico
|
Owned | Tow, Flake | ||
Spondon, Derby, UK(2)
|
Owned | Tow, Flake and Films | ||
Technical Polymers
Ticona
|
||||
Auburn Hills, Michigan, USA
|
Leased | Automotive Development Center | ||
Bishop, Texas, USA
|
Owned | POM (Celcon), PE-UHMW (GUR), Compounding | ||
Florence, Kentucky, USA
|
Owned | Compounding | ||
Kelsterbach, Germany(3)
|
Owned by InfraServ GmbH & Co. Kelsterbach KG, in which CAG holds a 100.0% limited partnership interest | LFT (Celstran), POM (Hostaform), Compounding | ||
Oberhausen, Germany
|
Owned by InfraServ GmbH & Co. Oberhausen KG, in which CAG holds an 84.0% limited partnership interest | PE-UHMW (GUR) | ||
Shelby, North Carolina, USA
|
Owned | LCP, PBT and PET (Celanex), Compounding | ||
Suzano, Brazil
|
Owned | Compounding | ||
Wilmington, North Carolina, USA
|
Owned by Fortron Industries LLC, a non-consolidated venture, in which we have a 50% interest, except for adjacent administrative office space which is leased by the venture | PPS (Fortron) | ||
Winona, Minnesota, USA
|
Owned | LFT (Celstran) |
30
Site
|
Leased/Owned
|
Products/Functions
|
||
Performance Products
|
||||
Frankfurt am Main, Germany
|
Owned by InfraServ GmbH & Co. Hoechst KG, in which CAG holds a 31.2% limited partnership interest | Sorbates, Sunett ® |
(1) | The Edmonton flake facility is expected to be closed in 2007. | |
(2) | Acquired in the January 2007 Acetate Products Limited acquisition. | |
(3) | Will be relocated as a result of the Frankfurt, Germany, Airport settlement. See Note 31 to the consolidated financial statements for additional information. |
Item 3. | Legal Proceedings |
Item 4. | Submission of Matters to a Vote of Security Holders |
31
36
37
52
79
F-9
F-40
F-41
F-71
F-86
Item 5.
Market
for the Registrants Common Equity, Related Stockholder
Matters and Issuer Purchases of Equity Securities
Price Range
High
Low
$
22.00
$
18.82
$
22.75
$
18.50
$
20.70
$
16.80
$
26.33
$
17.45
$
18.65
$
15.10
$
18.16
$
13.54
$
20.06
$
15.88
$
19.76
$
15.58
32
Table of Contents
33
Table of Contents
Index, S&P 500 Chemicals Index and S&P 500 Specialty
Chemicals Index % Return
to Shareholders, January 21, 2005 to December 31,
2006
Number of Securities to be
Weighted Average
Issued upon Exercise of
Exercise Price of
Number of Securities
Outstanding Options,
Outstanding Options,
Remaining Available
Warrants and Rights
Warrants and Rights
for Future Issuance
12,493,124
$
16.81
1,966,094
12,493,124
$
16.81
1,966,094
34
Table of Contents
Item 6.
Selected
Financial Data
35
Table of Contents
Successor
Predecessor
Nine Months
Three Months
Ended
Ended
Year Ended December 31,
December 31,
March 31,
Year Ended December 31,
2006
2005
2004
2004
2003
2002
(In $ millions, except per share and per share data)
6,656
6,033
3,718
1,209
4,451
3,704
5
34
1
107
(95
)
(15
)
(100
)
(83
)
(28
)
(17
)
4
747
573
72
46
93
153
664
374
(180
)
66
172
160
407
276
(258
)
51
127
107
(1
)
1
5
27
22
43
(1
)
18
406
277
(253
)
78
148
168
2.51
1.72
(2.60
)
1.03
2.57
2.44
2.37
1.66
(2.60
)
1.03
2.57
2.44
751
701
(62
)
(102
)
401
363
(268
)
(907
)
(1,811
)
91
(275
)
(139
)
(108
)
(144
)
2,686
(43
)
(108
)
(150
)
831
758
743
689
659
604
7,895
7,445
7,410
6,613
6,814
6,417
3,498
3,437
3,387
587
637
644
787
235
(112
)
2,622
2,582
2,096
283
286
181
70
289
240
252
212
160
44
211
203
0.16
0.08
0.48
(1)
Trade working capital is defined as trade accounts receivable
from third parties and affiliates net of allowance for doubtful
accounts, plus inventories, less trade accounts payable to third
parties and affiliates. Trade working capital is calculated in
the table below (2002 unaudited):
Table of Contents
Successor
Predecessor
December 31,
March 31,
December 31,
2006
2005
2004
2004
2003
2002
(In $ millions)
1,001
919
866
810
768
704
653
650
603
491
514
514
(823
)
(811
)
(726
)
(612
)
(623
)
(614
)
831
758
743
689
659
604
(2)
In the nine months ended December 31, 2004, CAG declared
and paid a dividend of 0.12 ($0.14) per share for the year
ended December 31, 2003. Dividends paid to Celanese and its
consolidated subsidiaries eliminate in consolidation.
Table of Contents
Table of Contents
changes in general economic, business, political and regulatory
conditions in the countries or regions in which we operate;
the length and depth of product and industry business cycles
particularly in the automotive, electrical, electronics and
construction industries;
changes in the price and availability of raw materials,
particularly changes in the demand for, supply of, and market
prices of fuel oil, natural gas, coal, electricity and
petrochemicals such as ethylene, propylene and butane, including
changes in production quotas in OPEC countries and the
deregulation of the natural gas transmission industry in Europe;
the ability to pass increases in raw material prices on to
customers or otherwise improve margins through price increases;
the ability to maintain plant utilization rates and to implement
planned capacity additions and expansions;
the ability to reduce production costs and improve productivity
by implementing technological improvements to existing plants;
increased price competition and the introduction of competing
products by other companies;
changes in the degree of patent and other legal protection
afforded to our products;
compliance costs and potential disruption or interruption of
production due to accidents or other unforeseen events or delays
in construction of facilities;
potential liability for remedial actions under existing or
future environmental regulations;
potential liability resulting from pending or future litigation,
or from changes in the laws, regulations or policies of
governments or other governmental activities in the countries in
which we operate;
changes in currency exchange rates and interest rates;
pending or future challenges to the domination and profit and
loss transfer agreement (Domination
Agreement); and
various other factors, both referenced and not referenced in
this document.
39
Table of Contents
40
Table of Contents
As noted above, in December 2006, we reached a settlement with
Fraport related to the planned Frankfurt airport expansion.
As noted above, in December 2006, we signed a definitive
agreement to sell our oxo products and derivative businesses,
including EOXO, a joint venture between CAG and Degussa, to
Advent International.
In December 2006, we sold our preferred interest in Pemeas GmbH
to BASF and received net proceeds from the sale of
9 million and recognized a gain of
8 million.
The Squeeze-Out (as defined in Note 2 to the consolidated
financial statements) was approved by the affirmative vote of
the majority of the votes cast at CAGs annual general
meeting in May 2006. As a result of the effective registration
of the Squeeze-Out in the commercial register in December 2006,
we acquired the remaining 2% of CAG in January 2007.
Announced plans to relocate the strategic management of the
Acetyls business to Shanghai, China, in 2007.
As a result of the Sponsors sale of 65,000,000 shares
of our Series A common stock in 2006, affiliates of the
Sponsor control less than a majority of the voting power of our
outstanding Series A common stock. As a result, we are no
longer a controlled company within the meaning of
the New York Stock Exchange rules and, thus, are required to
have a board of directors comprised of a majority of independent
directors and nominating and compensation committees composed
entirely of independent directors. However, we will phase in
these corporate governance requirements prior to May 15,
2007.
In August 2006, we signed a definitive agreement to purchase the
cellulose acetate flake, tow and film business of Acetate
Products Limited for a purchase price of approximately
£57 million ($110 million), subject to certain
adjustments as defined in the agreement. The transaction closed
on January 31, 2007. See Note 32 to the consolidated
financial statements for additional information.
In August 2006, we entered into an agreement with Degussa
pursuant to which Degussa granted us an option to purchase
Degussas interest in our EOXO venture. The option is
exercisable until June 30, 2007 and is subject to certain
conditions. In connection with the sale of our oxo products and
derivatives businesses noted above, we anticipate giving notice
to Degussa that we will exercise the option, subject to certain
conditions, to purchase their 50% interest, which will be
subsequently sold to Advent International. See Notes 6 and
32 to the consolidated financial statements for additional
information.
We shut down our Pentaerythritol (PE) operations
during the third quarter of 2006.
In July 2006, we made a $100 million equivalent voluntary
prepayment on our senior term loan facility. In connection with
the voluntary prepayment, we wrote off approximately
$1 million of unamortized deferred financing fees
associated with the senior term loan facility.
41
Table of Contents
In December 2005, we reached settlements with two insurers of
CNA Holdings pursuant to which CNA Holdings will be paid a total
of $16 million in the next two years ($7 million in
2006 and $9 million in 2007) in exchange for the
release of certain claims against the policy of the insurer. We
recorded approximately $30 million in income to other
(charges) gains, net for two plumbing action insurance
settlements in the fourth quarter of 2005.
In December 2005, we resolved litigation pertaining to antitrust
claims filed against certain shipping companies. Pursuant to
these agreements, we received net proceeds of approximately
$36 million which was recorded as a reduction to cost of
sales in the fourth quarter of 2005.
In December 2005, we announced a plan to develop our Nanjing,
China site into an integrated chemical complex that will include
a 600,000 metric ton acetic acid plant, a vinyl acetate unit and
a vinyl acetate emulsions unit. Startup is targeted for the
first half of 2007.
In December 2005, we sold our Cyclo-olefine Copolymer business
(COC) to a venture of Japans Daicel Chemical
Industries Ltd. (Daicel) and Polyplastics Co, Ltd.
(Polyplastics). Daicel holds a majority stake in the
venture with 55% interest and Polyplastics, which itself is a
venture between us and Daicel, owns the remaining 45%. The
transaction resulted in a loss of approximately $35 million.
In December 2005, we completed the sale of our common stock
interest in the Pemeas GmbH fuel cell venture and recognized a
gain of less than $1 million.
In December 2005, we announced that discussions regarding the
venture project being developed by Acetex and Tasnee
Petrochemicals in the Kingdom of Saudi Arabia have been
temporarily suspended due to the current high demand on
contractors and vendors which have affected expected project
costs.
In December 2005, we announced our intention to pursue strategic
alternatives for our Pampa, Texas plant. The facility, which
produces a variety of products based on butane, including
290,000 metric tons of acetic acid, faces competitive pressures
due to the technology utilized.
Increased our ownership of CAG to approximately 98% as of
November 2, 2005 following an agreement with major
shareholders and ongoing tender offers. In November 2005, our
Board of Directors granted approval to effect a Squeeze-Out of
the remaining minority shareholders of CAG. See Note 2 to
the consolidated financial statements for additional information.
In the fourth quarter of 2005, we exited our filament business
(See Note 6 to the notes to consolidated financial
statements).
In October 2005, we completed the sale of our acetate
manufacturing facility in Rock Hill, South Carolina to Greens of
Rock Hill LLC. Production at the facility was phased out earlier
in 2005 as part of our previously announced plans to consolidate
our acetate flake manufacturing operations. We recognized a gain
on sale of approximately $23 million, which includes the
reversal of $12 million of asset retirement obligations and
$7 million of environmental reserves, as the purchaser
assumed these obligations.
In August 2005, our board adopted a dividend policy and we began
to pay common shareholders a dividend of $0.16 per share
annually, or 1%, based on the initial public offering price of
$16 per share.
In July 2005, we completed the acquisition of Acetex Corporation
for $270 million and assumed Acetexs
$247 million of debt, which is net of cash acquired of
$54 million. We also redeemed Acetexs outstanding
10
7
/
8
% senior
notes primarily with available cash of $280 million. See
Note 6 to the consolidated financial statements for
additional information.
Completed the transition to purchase our total requirements for
Gulf Coast methanol from Southern Chemical Corporation, a
Trinidad-based supplier.
Announced plans to construct a world-scale plant for the
manufacture of
GUR
®
ultra-high molecular weight polyethylene in Asia. Production is
expected to begin in the second half of 2007.
42
Table of Contents
Announced plans to implement our next generation of vinyl
acetate monomer technology, known as Vantage
Plus
tm
.
We expect to further improve production efficiency and lower
operating costs across our global manufacturing platform through
the use of this technology.
Continued to focus the product portfolio by exiting
non-strategic businesses, such as the high performance polymer
polybenzamidazole (PBI), vectran polymer and
emulsion powders.
In February 2005, we completed the acquisition of Vinamul, the
North American and European emulsion polymer business of
Imperial Chemical Industries PLC (ICI) for
$208 million. See Note 6 to the consolidated financial
statements for additional information.
In January 2005, we completed an initial public offering of
50,000,000 shares of Series A common stock.
Concurrently, we issued 9,600,000 shares of convertible
perpetual preferred stock. See Note 3 to the consolidated
financial statements for additional information.
In December 2004, we approved a stock incentive plan for
executive officers, key employees and directors, a deferred
compensation plan for executive officers and key employees, as
well as other management incentive programs.
In November 2004, Blackstone Crystal Holdings Capital Partners
(Cayman) IV Ltd., reorganized as a Delaware company and changed
its name to Celanese Corporation.
In response to greater demand for Ticonas technical
polymers, two projects were announced to expand manufacturing
capacity. Ticona announced plans to increase production of
polyacetal in North America by about 20%, raising total capacity
to 102,000 tons per year at the Bishop, Texas facility. This
project was completed in October 2004.
In October 2004, we completed an organizational restructuring.
See Note 2 to the consolidated financial statements.
In October 2004, we announced plans to implement a strategic
restructuring of our acetate business to increase efficiency,
reduce overcapacity in certain areas and to focus on products
and markets that provide long-term value. The restructuring
resulted in $50 million of asset impairment charges
recorded as an other (charge) gain, net and $12 million in
charges to depreciation for related asset retirement obligations
for the nine months ended December 31, 2004.
43
Table of Contents
Successor
Predecessor
Year
Year
Nine Months
Nine Months
Three Months
Three Months
Ended
Ended
Ended
Ended
Ended
Ended
December 31,
December 31,
December 31,
December 31,
March 31,
March 31,
2006
2005
2005
2004
2005
2004
(Unaudited)
(Unaudited)
(In $ millions, except percentages)
6,656
6,033
4,564
3,718
1,469
1,209
(538
)
(511
)
(363
)
(454
)
(148
)
(136
)
5
34
34
1
(15
)
(100
)
(62
)
(83
)
(38
)
(28
)
747
573
417
72
156
46
86
61
46
36
15
12
(294
)
(387
)
(211
)
(300
)
(176
)
(6
)
664
374
361
(180
)
13
66
(253
)
(61
)
(53
)
(70
)
(8
)
(15
)
407
276
296
(258
)
(20
)
51
(1
)
1
(9
)
5
10
27
406
277
287
(253
)
(10
)
78
283
286
223
181
63
70
11.2
%
9.5
%
9.1
%
1.9
%
10.6
%
3.8
%
10.0
%
6.2
%
7.9
%
(4.8
)%
0.9
%
5.5
%
(1)
Defined as operating profit divided by net sales.
Successor
As of
As of
December 31,
December 31,
2006
2005
(In $ millions)
309
155
3,189
3,282
3,498
3,437
791
390
2,707
3,047
44
Table of Contents
Successor
Year Ended
Year Ended
December 31,
December 31,
2006
2005
(In $ millions)
(12
)
(23
)
1
(4
)
(11
)
(27
)
(12
)
5
34
(25
)
(4
)
(36
)
(10
)
(66
)
45
Table of Contents
46
Table of Contents
47
Table of Contents
Successor
Predecessor
Nine Months Ended
Three Months Ended
December 31,
December 31,
March 31,
March 31,
2005
2004
2005
2004
(Unaudited)
(Unaudited)
(In $ millions)
(21
)
(8
)
(2
)
(2
)
(3
)
(45
)
(1
)
3
(24
)
(50
)
(3
)
(2
)
(12
)
34
1
(25
)
(32
)
(1
)
(1
)
(35
)
(26
)
(28
)
(82
)
(38
)
(28
)
48
Table of Contents
49
Table of Contents
50
Table of Contents
Successor
Predecessor
Year Ended December 31,
Nine Months Ended December 31,
Three Months Ended March 31,
Change
Change
Change
2006
2005
in $
2005
2004
in $
2005
2004
in $
(Unaudited)
(Unaudited)
(In $ millions)
4,742
4,299
443
3,264
2,547
717
1,035
809
226
915
887
28
648
636
12
239
227
12
700
659
41
494
441
53
165
147
18
176
180
(4
)
133
131
2
47
44
3
257
144
113
132
45
87
12
11
1
(134
)
(136
)
2
(107
)
(82
)
(25
)
(29
)
(29
)
6,656
6,033
623
4,564
3,718
846
1,469
1,209
260
(7
)
(18
)
11
(17
)
(3
)
(14
)
(1
)
(1
)
6
8
(2
)
9
(37
)
46
(1
)
(1
)
1
(9
)
10
(8
)
(41
)
33
(1
)
(1
)
(10
)
(47
)
37
(12
)
(1
)
(11
)
(35
)
(26
)
(9
)
(10
)
(66
)
56
(28
)
(82
)
54
(38
)
(28
)
(10
)
637
585
52
408
248
160
177
64
113
145
60
85
21
(12
)
33
39
31
8
106
67
39
57
(17
)
74
10
4
6
50
51
(1
)
38
18
20
13
11
2
(191
)
(190
)
(1
)
(107
)
(165
)
58
(83
)
(64
)
(19
)
747
573
174
417
72
345
156
46
110
709
667
42
474
265
209
193
63
130
201
116
85
65
26
39
51
45
6
128
71
57
61
(13
)
74
10
4
6
49
46
3
34
15
19
12
11
1
(423
)
(526
)
103
(273
)
(473
)
200
(253
)
(57
)
(196
)
664
374
290
361
(180
)
541
13
66
(53
)
51
Table of Contents
Successor
Predecessor
Year Ended December 31,
Nine Months Ended December 31,
Three Months Ended March 31,
Change
Change
Change
2006
2005
in $
2005
2004
in $
2005
2004
in $
(Unaudited)
(Unaudited)
(In $ millions)
155
167
(12
)
133
89
44
34
39
(5
)
65
60
5
45
48
(3
)
15
16
(1
)
24
29
(5
)
20
30
(10
)
9
11
(2
)
15
13
2
10
10
3
2
1
24
17
7
15
4
11
2
2
283
286
(3
)
223
181
42
63
70
(7
)
Table of Contents
Volume
Price
Currency
Other
Total
In percentages
(1
)
22
3
4
28
2
3
5
9
3
12
9
(7
)
5
7
1
15
2
2
21
(a)
Includes net sales from the Acetex business, excluding AT
Plastics
(b)
Includes loss of sales related to the COC divestiture
(c)
Includes the effects of AT Plastics and the captive insurance
companies
53
Table of Contents
Successor
Year Ended
December 31,
December 31,
Change
2006
2005
in $
In $ millions (except for percentages)
4,742
4,299
443
1
%
5
%
1
%
3
%
637
585
52
13.4
%
13.6
%
(7
)
(18
)
11
709
667
42
155
167
(12
)
54
Table of Contents
Successor
Year Ended
December 31,
December 31,
Change
2006
2005
in $
In $ millions (except for percentages)
915
887
28
6
%
0
%
(1
)%
(2
)%
145
60
85
15.8
%
6.8
%
6
8
(2
)
201
116
85
65
60
5
55
Table of Contents
Successor
Year Ended
December 31,
December 31,
Change
2006
2005
in $
In $ millions (except for percentages)
700
659
41
(1
)%
7
%
0
%
0
%
106
67
39
15.1
%
10.2
%
1
(9
)
10
128
71
57
24
29
(5
)
56
Table of Contents
Successor
Year Ended
December 31,
December 31,
Change
2006
2005
in $
In $ millions (except for percentages)
176
180
(4
)
7
%
(9
)%
0
%
0
%
50
51
(1
)
28.4
%
28.3
%
49
46
3
15
13
2
57
Table of Contents
Successor
Predecessor
Nine Months Ended
Three Months Ended
December 31,
December 31,
Change
March 31,
March 31,
Change
2005
2004
in $
2005
2004
in $
(Unaudited)
(Unaudited)
In $ millions (except for percentages)
3,264
2,547
717
1,035
809
226
(3
)%
(1
)%
15
%
22
%
0
%
3
%
16
%
4
%
408
248
160
177
64
113
12.5
%
9.7
%
17.1
%
7.9
%
(17
)
(3
)
(14
)
(1
)
(1
)
474
265
209
193
63
130
133
89
44
34
39
(5
)
58
Table of Contents
Successor
Predecessor
Nine Months Ended
Three Months Ended
December 31,
December 31,
Change
March 31,
March 31,
Change
2005
2004
in $
2005
2004
in $
(Unaudited)
(Unaudited)
In $ millions (except for percentages)
648
636
12
239
227
12
(1
)%
2
%
4
%
0
%
(1
)%
3
%
0
%
0
%
21
(12
)
33
39
31
8
3.2
%
(1.9
)%
16.3
%
13.7
%
9
(37
)
46
(1
)
(1
)
65
26
39
51
45
6
45
48
(3
)
15
16
(1
)
59
Table of Contents
Successor
Predecessor
Nine Months Ended
Three Months Ended
December 31,
December 31,
Change
March 31,
March 31,
Change
2005
2004
in $
2005
2004
in $
(Unaudited)
(Unaudited)
In $ millions (except for percentages)
494
441
53
165
147
18
7
%
9
%
5
%
3
%
0
%
0
%
0
%
0
%
57
(17
)
74
10
4
6
11.5
%
(3.9
)%
6.1
%
2.7
%
(8
)
(41
)
33
(1
)
(1
)
61
(13
)
74
10
4
6
20
30
(10
)
9
11
(2
)
60
Table of Contents
61
Table of Contents
Successor
Predecessor
Nine Months Ended
Three Months Ended
December 31,
December 31,
Change
March 31,
March 31,
Change
2005
2004
in $
2005
2004
in $
(Unaudited)
(Unaudited)
In $ millions (except for percentages)
133
131
2
47
44
3
6
%
9
%
(4
)%
(7
)%
0
%
5
%
0
%
0
%
38
18
20
13
11
2
28.6
%
13.7
%
27.7
%
25
%
34
15
19
12
11
1
10
10
3
2
1
62
Table of Contents
63
Table of Contents
64
Table of Contents
Borrowings under the term loan facility of $1,135 million.
Distribution to Series B shareholders of $804 million.
Redemption and related premiums of the senior subordinated notes
of $572 million and senior discount notes of
$207 million.
Proceeds from the issuances of common stock, net of
$752 million and preferred stock, net of $233 million.
Repayment of floating rate term loan, including related premium,
of $354 million.
Exercise of Acetexs option to redeem its
10
7
/
8
% senior
notes for approximately $280 million.
Payment of cash dividends of $13 million on our
Series A common stock and $8 million on our
convertible preferred stock.
65
Table of Contents
66
Table of Contents
Less Than
After 5
Total
1 Year
Years 2 & 3
Years 4 & 5
Years
(In $ millions)
1,622
115
31
1,476
1,843
239
483
480
641
967
967
554
554
25
3
4
5
13
464
191
40
43
190
5,475
548
558
2,004
2,365
339
75
121
75
68
2,229
245
500
419
1,065
355
239
81
33
2
8,398
1,107
1,260
2,531
3,500
(1)
For future interest expense, we assumed no change in variable
rates. See Note 16 in the consolidated financial statements
for the applicable interest rates.
(2)
Does not include a $3 million premium.
(3)
Reflects an additional $134 million representing the
accreted value of the notes at maturity.
(4)
Does not include a $2 million reduction due to purchase
accounting.
67
Table of Contents
75% (such percentage will be reduced to 50% if BCP
Crystals leverage ratio is less than 3.00 to 1.00 for any
fiscal year ending on or after December 31, 2005) of
BCP Crystals excess cash flow;
100% of the net cash proceeds of all non-ordinary course asset
sales and casualty and condemnation events, unless BCP Crystal
reinvests or contracts to reinvest those proceeds in assets to
be used in BCP Crystals business or to make certain other
permitted investments within 12 months, subject to certain
limitations;
100% of the net cash proceeds of any incurrence of debt other
than debt permitted under the senior credit facilities, subject
to certain exceptions; and
68
Table of Contents
Expiration per period
Less Than
After 5
Total
1 Year
Years 2 & 3
Years 4 & 5
Years
(In $ millions)
41
7
15
16
3
218
218
259
225
15
16
3
69
Table of Contents
Spending for
Spending for
2007
the Year Ended
the Year Ended
Projected
December 31,
December 31,
Spending
2006
2005
(In $ millions)
45
71
84
104
112
111
149
183
195
70
Table of Contents
71
Table of Contents
72
Table of Contents
73
Table of Contents
74
Table of Contents
75
Table of Contents
76
Table of Contents
Item 7A.
Quantitative
and Qualitative Disclosures about Market Risk
77
Table of Contents
Item 8.
Financial
Statements and Supplementary Data
Successor
Three Months
Three Months
Three Months
Three Months
Ended
Ended
Ended
Ended
March 31,
June 30,
September 30,
December 31,
2006
2006
2006
2006
(Unaudited)
(In $ millions except for share and per share data)
1,646
1,669
1,685
1,656
1
2
2
(1
)
(14
)
197
165
200
185
161
148
181
174
116
105
107
79
1
(2
)
2
(2
)
117
103
109
77
0.72
0.64
0.67
0.47
0.67
0.60
0.64
0.45
78
Table of Contents
Successor
Three Months
Three Months
Three Months
Three Months
Ended
Ended
Ended
Ended
March 31,
June 30,
September 30,
December 31,
2005
2005
2005
2005
(Unaudited)
(In $ millions except for share and per share data)
1,469
1,498
1,526
1,540
4
30
(38
)
(31
)
(24
)
(7
)
156
155
95
167
13
126
77
158
(20
)
69
47
180
10
(2
)
(2
)
(5
)
(10
)
67
45
175
(0.08
)
0.41
0.26
1.08
(0.08
)
0.39
0.26
1.02
Table of Contents
Item 9.
Changes
in and Disagreements with Accountants on Accounting and
Financial Disclosure
Item 9A.
Controls
and Procedures
80
Table of Contents
Celanese Corporation:
81
Table of Contents
Item 9B.
Other
Information
Item 10.
Directors
and Executive Officers of the Registrant
Item 11.
Executive
Compensation
Item 12.
Security
Ownership of Certain Beneficial Owners and Management and
Related Stockholder Matters
Item 13.
Certain
Relationships and Related Transactions
Item 14.
Principal
Accounting Fees and Services
Item 15.
Exhibits
and Financial Statement Schedules
Page Number
F-2
F-4
F-5
F-6
F-7
F-8
82
Table of Contents
83
Table of Contents
By:
Title:
Chairman of the Board of Directors,
Chief Executive Officer and
Chairman of the Board of
Directors, Chief Executive Officer
(Principal Executive Officer) and
President
February 21, 2007
Executive Vice President,
Chief Financial Officer
(Principal Financial Officer)
February 21, 2007
Vice President, Controller
(Principal Accounting Officer)
February 21, 2007
Director
February 21, 2007
Director
February 21, 2007
84
Table of Contents
Director
February 21, 2007
Director
February 21, 2007
Director
February 21, 2007
Director
February 21, 2007
Director
February 21, 2007
Director
February 21, 2007
Director
February 21, 2007
Director
February 21, 2007
85
Table of Contents
Page
F-2
F-4
F-5
F-6
F-7
F-8
F-1
Table of Contents
F-2
Table of Contents
F-3
Table of Contents
Successor
Predecessor
Nine Months
Three Months
Year Ended
Year Ended
Ended
Ended
December 31,
December 31,
December 31,
March 31,
2006
2005
2004
2004
(In $ millions, except for share and per share data)
6,656
6,033
3,718
1,209
(5,214
)
(4,731
)
(3,000
)
(975
)
1,442
1,302
718
234
(538
)
(511
)
(454
)
(136
)
(66
)
(51
)
(43
)
(70
)
(91
)
(67
)
(23
)
5
34
1
(15
)
(100
)
(83
)
(28
)
(2
)
(3
)
(9
)
(10
)
3
(1
)
747
573
72
46
86
61
36
12
(294
)
(387
)
(300
)
(6
)
37
38
24
5
88
89
(12
)
9
664
374
(180
)
66
(253
)
(61
)
(70
)
(15
)
411
313
(250
)
51
(4
)
(37
)
(8
)
407
276
(258
)
51
(8
)
(3
)
3
1
5
2
13
2
4
13
(1
)
1
5
27
406
277
(253
)
78
(10
)
(10
)
396
267
(253
)
78
2.51
1.72
(2.60
)
1.03
(0.01
)
0.01
0.05
0.55
2.50
1.73
(2.55
)
1.58
2.37
1.66
(2.60
)
1.03
(0.01
)
0.01
0.05
0.54
2.36
1.67
(2.55
)
1.57
158,597,424
154,402,575
99,377,884
49,321,468
171,807,599
166,200,048
99,377,884
49,712,421
F-4
Table of Contents
F-5
Table of Contents
Accumulated
Retained
other
Preferred Stock
Common Stock
Additional
Earnings
Comprehensive
Total
Number
Number of
Paid-in
(Accumulated
Income (Loss),
Treasury
Shareholders
of Shares
Amount
Shares
Amount
Capital
Deficit)
Net
Stock
Equity (Deficit)
(In $ millions, except share and per share data)
49,321,468
150
2,714
25
(198
)
(109
)
2,582
78
78
7
7
(46
)
(46
)
(39
)
(39
)
39
1
1
49,321,468
150
2,715
103
(237
)
(109
)
2,622
99,377,884
641
641
(253
)
(253
)
(7
)
(7
)
7
7
2
2
(19
)
(19
)
(17
)
(17
)
(270
)
3
3
(500
)
(500
)
14
14
99,377,884
158
(253
)
(17
)
(112
)
(99,377,884
)
151,062,161
9,600,000
7,500,000
277
277
3
3
(117
)
(117
)
5
5
(109
)
(109
)
168
5
5
(13
)
(13
)
(8
)
(8
)
752
752
233
233
12
12
2
2
(804
)
(804
)
9,600,000
158,562,161
337
24
(126
)
235
106,505
2
2
406
406
13
13
2
2
137
137
5
5
157
157
563
3
3
(26
)
(26
)
(10
)
(10
)
20
20
9,600,000
158,668,666
362
394
31
787
F-6
Table of Contents
Successor
Predecessor
Nine Months
Three Months
Year Ended
Year Ended
Ended
Ended
December 31,
December 31,
December 31,
March 31,
2006
2005
2004
2004
(In $ millions)
406
277
(253
)
78
(34
)
30
47
20
20
2
202
218
140
67
81
68
41
3
13
41
98
40
40
14
27
5
(14
)
4
125
(85
)
19
(14
)
(8
)
7
(3
)
4
37
8
74
21
5
(2
)
3
(146
)
(28
)
31
(24
)
(87
)
(6
)
12
110
(37
)
16
17
(22
)
(10
)
12
(57
)
(8
)
14
(21
)
17
96
(7
)
45
17
10
38
(58
)
(50
)
(376
)
(22
)
(85
)
(24
)
39
3
(5
)
28
(8
)
(8
)
751
701
(62
)
(102
)
(252
)
(212
)
(160
)
(44
)
(43
)
(918
)
(1,633
)
23
48
31
(8
)
21
(1
)
(5
)
75
139
26
95
221
132
42
(65
)
(149
)
(173
)
(42
)
(42
)
(6
)
(2
)
7
(1
)
1
(268
)
(907
)
(1,811
)
91
641
(804
)
(500
)
200
(221
)
764
233
(125
)
(1,449
)
(254
)
(27
)
38
16
2,338
1,135
608
13
22
36
(16
)
(31
)
2
29
(9
)
(205
)
(36
)
(21
)
14
(108
)
(144
)
2,686
(43
)
26
(98
)
25
(1
)
401
(448
)
838
(55
)
390
838
148
791
390
838
93
F-7
Table of Contents
1.
Description
of the Company
2.
Acquisition
of CAG
As of April 1,
2004
(In $ millions)
93
1,468
568
125
777
1,726
518
433
747
6,455
F-8
Table of Contents
As of April 1,
2004
(In $ millions)
279
599
1,166
306
1,370
558
4,278
451
1,726
Table of Contents
F-10
Table of Contents
F-11
Table of Contents
Year Ended December 31,
2005
2004
(In $ millions)
6,033
4,927
575
218
318
(76
)
F-12
Table of Contents
3.
Initial
Public Offering and Concurrent Financings
4.
Summary
of Accounting Policies
F-13
Table of Contents
Predecessor
Three Months Ended
March 31, 2004
(In $ millions, except
per share data)
67
17
(6
)
78
1.36
0.22
1.58
1.35
0.22
1.57
(1)
Per-share data are based on weighted average shares outstanding.
F-14
Table of Contents
20 years
30 years
20 years
F-15
Table of Contents
F-16
Table of Contents
F-17
Table of Contents
F-18
Table of Contents
Ownership Percentage
December 31,
December 31,
2006
2005
98%
98%
98%
98%
76%
76%
50%
50%
F-19
Table of Contents
5.
Recent
accounting pronouncements
F-20
Table of Contents
F-21
Table of Contents
6.
Acquisitions,
divestitures and ventures
On April 6, 2004, the Company acquired 84% of CAG. During
2005, the Company acquired an additional 14% of CAG (See
Note 2). As a result of the effective registration of the
Squeeze-Out in the commercial register in December 2006, the
Company acquired the remaining 2% of CAG in January 2007.
In February 2005, the Company acquired Vinamul, the North
American and European emulsion polymer business of Imperial
Chemical Industries PLC (ICI) for $208 million,
in addition to direct acquisition costs of $9 million.
Vinamul operates manufacturing facilities in the United States,
Canada, the United Kingdom,
F-22
Table of Contents
and the Netherlands. As part of the agreement, ICI will continue
to supply Vinamul with starch, dextrin and other specialty
ingredients following the acquisition. The Company will supply
ICI with vinyl acetate monomer and polyvinyl alcohols. The
supply agreements are for fifteen years, and the pricing is
based on market and other negotiated terms. The fair value of
the supply contract was approximately $11 million and was
recorded as deferred revenue to be amortized over the fifteen
year life of the agreement. The Company primarily financed this
acquisition through borrowings of $200 million under the
amended and restated senior credit facilities (See
Note 16). Pro forma financial information has not been
provided as the acquisition did not have a material impact on
the Companys results of operations.
In July 2005, the Company acquired Acetex Corporation
(Acetex) for $270 million, in addition to
direct acquisition costs of $16 million and assumed
Acetexs $247 million of debt, which is net of cash
acquired of $54 million. Acetex has two primary
businesses its Acetyls business and its Specialty
Polymers and Films business. The Acetyls business is operated in
Europe and the Polymers and Film businesses are operated in
North America. The Company acquired Acetex using existing cash.
Pro forma financial information has not been provided as the
acquisition did not have a material impact on the Companys
results of operations.
Vinamul
Acetex
(In $ millions)
10
54
24
79
152
285
44
166
22
62
(316
)
(34
)
(28
)
(1
)
(16
)
217
286
In August 2006, the Company signed a definitive agreement to
purchase the cellulose acetate flake, tow and film business of
Acetate Products Limited for a purchase price of approximately
£57 million ($110 million), subject to certain
adjustments as defined in the agreement. The transaction closed
on January 31, 2007. See Note 32 for further
information.
In August 2005, the Company and Hatco Corporation agreed to wind
up Estech GmbH, its venture for neopropyl esters. The Company
recorded an impairment charge of $10 million, included in
Equity in net earnings of affiliates, related to this matter in
the year ended December 31, 2005.
In April 2004, the Company and a group of investors led by
Conduit Ventures Ltd. entered into a venture, which was named
Pemeas GmbH. This venture was formed in order to advance the
commercialization of the Companys fuel cell technology.
Pemeas GmbH was considered a variable interest entity as defined
under FIN No. 46. The Company was deemed the primary
beneficiary of this variable interest entity and, accordingly,
consolidated this entity in its consolidated financial
statements. In the period the Company adopted
FIN No. 46, the consolidation of this entity did not
have a material impact on the Companys financial position
or results of operations and cash flows. In December 2005, the
Company sold its common stock interest in Pemeas GmbH, which
resulted in the Company no longer being the primary beneficiary.
F-23
Table of Contents
The Company recognized a gain of less than $1 million
related to this sale. In December 2006, the Company sold its
preferred interest in Pemeas GmbH to BASF, received net proceeds
from the sale of 9 million and recognized a gain of
8 million ($11 million). This amount is included
in Other income (expense), net in the consolidated statement of
operations.
On October 1, 2003, Celanese AG and Degussa AG
(Degussa) completed the combination of their
European oxo businesses. The venture, European Oxo GmbH
(EOXO), consists of both companies
propylene-based oxo chemical activities. CAG contributed net
assets with a carrying value of $12 million for a 50%
interest in the venture. CAG retained substantially all the
accounts receivable, accounts payable and accrued liabilities of
its contributed business existing on September 30, 2003. In
addition, CAG and Degussa each committed to fund the venture
equally. Under a multi-year agreement, Degussa has the option to
sell its share in EOXO to the Company beginning in January 2008
for a price based on a formula which considers the profitability
and net debt of the venture and the purchase price of rhodium.
On August 28, 2006, Celanese Chemicals Europe GmbH
(CCE), a wholly owned subsidiary of CAG, entered
into an agreement with Degussa pursuant to which Degussa granted
CCE an option to purchase Degussas interest in EOXO for a
purchase price not materially different than the previously
described formula and the assumption of certain liabilities. The
option is exercisable until June 30, 2007 and is subject to
certain conditions. Degussa has given notice that if CCE does
not exercise its option to purchase by June 30, 2007,
Degussa will exercise its right to sell its interest in EOXO to
the Company beginning in 2008 for a price based on the
aforementioned formula. In connection with the sale of the
Companys oxo products and derivatives business, the
Company anticipates giving notice to Degussa that it will
exercise the option, subject to certain conditions, to purchase
their 50% interest, which will be subsequently sold to Advent
International (See Note 32). The Companys European
oxo business is part of its Chemical Products segment. The
Company reports its investment in EOXO using the equity method
of accounting.
Successor
Predecessor
Nine Months
Three Months
Year Ended
Year Ended
Ended
Ended
December 31,
December 31,
December 31,
March 31,
2006
2005
2004
2004
(In $ millions)
12
82
131
67
(14
)
(76
)
(115
)
(64
)
(2
)
6
16
3
(8
)
(3
)
3
1
5
2
13
2
4
13
(1
)
1
5
27
During the third quarter of 2006, the Company discontinued its
Pentaerythritol (PE) operations, which were included
in the Chemical Products segment. As a result, the earnings
(loss) from operations related to
F-24
Table of Contents
the PE operations are reflected as a component of discontinued
operations in the consolidated statements of operations
.
In October 2004, the Company announced plans to implement a
strategic restructuring of its acetate business to increase
efficiency, reduce overcapacity in certain areas and to focus on
products and markets that provide long-term value. As part of
this restructuring, the Company announced its plans to
discontinue its filament operations, which were included in the
Acetate Products segment, prior to December 31, 2005 and to
consolidate its acetate flake and tow manufacturing operations.
During the fourth quarter of 2005, the Company discontinued its
filament operations. As a result, the earnings (loss) from
operations related to the filament operations are reflected as a
component of discontinued operations in the consolidated
statements of operations
.
In July 2005, in connection with the Vinamul transaction, the
Company agreed to sell its emulsion powders business to ICI for
approximately $25 million. This transaction included a
supply agreement whereby the Company supplies product to ICI for
a period of up to fifteen years. In connection with the sale,
the Company reduced goodwill related to the acquisition of
Vinamul by $6 million. The transaction closed in September
2005.
In October 2005, the Company sold its Rock Hill, SC
manufacturing facility for $4 million in cash. As a result
the Company derecognized $12 million of asset retirement
obligations and $7 million of environmental liabilities
which were legally transferred to the buyer, and recorded a gain
of $23 million.
In December 2005, the Company sold its Cyclo-olefine Copolymer
(COC) business to a venture of Japans Daicel
Chemical Industries Ltd. (Daicel) and Polyplastics
Co. Ltd. (Polyplastics). Daicel holds a majority
stake in the venture with 55% interest and Polyplastics, which
itself is a venture between the Company and Daicel, owns the
remaining 45%. The transaction resulted in a loss of
approximately $35 million.
7.
Securities
Available for Sale
F-25
Table of Contents
Amortized
Unrealized
Unrealized
Fair
Cost
Gain
Loss
Value
(In $ millions)
69
1
(1
)
69
54
(1
)
53
123
1
(2
)
122
10
10
59
11
70
58
(1
)
57
6
6
256
12
(3
)
265
77
(3
)
74
73
(1
)
72
150
(4
)
146
1
1
65
2
67
63
(2
)
61
5
5
284
2
(6
)
280
Amortized
Cost
Fair Value
(In $ millions)
30
30
56
55
47
46
63
64
196
195
(1)
Proceeds received from fixed maturities that mature within one
year are expected to be reinvested into additional securities
upon such maturity.
F-26
Table of Contents
8.
Receivables,
net
Successor
As of
As of
December 31,
December 31,
2006
2005
(In $ millions)
1,017
935
(16
)
(16
)
1,001
919
85
117
390
364
1,476
1,400
9.
Inventories
Successor
As of
As of
December 31,
December 31,
2006
2005
(In $ millions)
500
504
33
27
120
119
653
650
F-27
Table of Contents
10.
Investments
Carrying
Share of Earnings (Loss)
Ownership Percentage
Value
Successor
Predecessor
Successor
Successor
Nine Months
Three Months
As of
As of
As of
As of
Year Ended
Year Ended
Ended
Ended
December 31,
December 31,
December 31,
December 31,
December 31,
December 31,
December 31,
March 31,
2006
2005
2006
2005
2006
2005
2004
2004
(In $ millions)
Chemical Products
51.0
%
51.0
%
(10
)
(3
)
Chemical Products
50.0
%
50.0
%
26
13
10
10
(5
)
(3
)
Chemical Products
45.0
%
45.0
%
1
1
Technical Polymers Ticona
(Ticona)
50.0
%
50.0
%
63
57
14
11
6
2
Ticona
50.0
%
50.0
%
160
146
13
14
11
3
Ticona
45.0
%
45.0
%
136
179
26
24
17
7
Other
39.0
%
39.0
%
26
23
4
4
3
1
Other
31.2
%
31.2
%
136
115
14
7
5
2
Other
28.2
%
28.2
%
18
17
1
1
1
Performance Products
10.0
%
10.0
%
4
4
1
1
570
555
83
61
36
12
Successor
Predecessor
Nine Months
Three Months
Year Ended
Year Ended
Ended
Ended
December 31,
December 31,
December 31,
March 31,
2006
2005
2004
2004
(In $ millions)
197
138
94
27
83
(1)
61
36
12
109
66
22
16
(1)
Amount does not include a $3 million liquidating dividend
from Clear Lake Methanol Partners.
Successor
As of
As of
December 31,
December 31,
2006
2005
(In $ millions)
2,505
2,295
1,411
1,183
675
679
419
433
151
122
570
555
F-28
Table of Contents
Successor
Successor
Ownership
Ownership
Carrying Value
Carrying Value
% as of
% as of
As of
As of
December 31,
December 31,
December 31,
December 31,
2006
2005
2006
2005
(In $ millions)
25
%
25
%
54
54
30
%
30
%
15
15
31
%
31
%
77
77
30
%
30
%
15
15
8
%
8
%
6
13
26
46
193
220
11.
Property,
Plant and Equipment
Successor
As of
As of
December 31,
December 31,
2006
2005
(In $ millions)
64
56
51
52
353
335
2,089
1,890
285
173
2,842
2,506
(687
)
(475
)
2,155
2,031
F-29
Table of Contents
12.
Goodwill
Chemical
Acetate
Performance
Products
Products
Ticona
Products
Other
Total
(In $ millions)
193
180
290
84
747
(11
)
8
(16
)
(7
)
(26
)
149
17
166
44
44
5
11
2
18
380
188
285
79
17
949
17
(6
)
11
(27
)
(32
)
(26
)
(1
)
(86
)
(2
)
(3
)
6
1
368
156
256
84
11
875
F-30
Table of Contents
13.
Intangible
Assets
Successor
As of
As of
December 31,
December 31,
2006
2005
(In $ millions)
74
73
526
474
12
12
15
11
627
570
(164
)
(89
)
463
481
14.
Other
Current Liabilities
Successor
As of
As of
December 31,
December 31,
2006
2005
(In $ millions)
198
159
26
25
34
45
68
141
148
129
313
288
787
787
F-31
Table of Contents
15.
Other
Liabilities
Successor
As of
As of
December 31,
December 31,
2006
2005
(In $ millions)
88
99
86
87
269
254
443
440
Successor
Predecessor
Nine Months
Three Months
Year Ended
Year Ended
Ended
Ended
December 31,
December 31,
December 31,
March 31,
2006
2005
2004
2004
(In $ millions)
54
52
48
47
10
9
12
3
4
1
1
(2
)
(9
)
(1
)
(1
)
(12
)
9
(9
)
(7
)
(1
)
1
1
1
2
59
54
52
48
(1)
Relates to sale of the Rock Hill plant (See Note 6).
F-32
Table of Contents
16.
Debt
Successor
As of
As of
December 31,
December 31,
2006
2005
(In $ millions)
127
20
182
135
309
155
1,622
1,708
799
800
171
153
339
306
81
73
14
14
191
191
30
28
69
29
3,316
3,302
127
20
3,189
3,282
Successor
Predecessor
Nine Months
Three Months
Year Ended
Year Ended
Ended
Ended
December 31,
December 31,
December 31,
March 31,
2006
2005
2004
2004
(In $ millions)
1
28
89
74
21
293
285
190
6
294
387
300
6
F-33
Table of Contents
F-34
Table of Contents
incur additional indebtedness or issue preferred stock;
pay dividends on or make other distributions or repurchase the
respective issuers capital stock;
make investments;
enter into certain transactions with affiliates;
limit dividends or other payments by BCP Crystals
restricted subsidiaries to it;
create liens or other pari passu on subordinated indebtedness
without securing the respective notes;
F-35
Table of Contents
designate subsidiaries as unrestricted subsidiaries; and
sell certain assets or merge with or into other companies.
Total
(In $ millions)
309
25
50
39
1,485
1,590
3,498
(1)
Includes $2 million purchase accounting adjustment to
assumed debt.
17.
Benefit
Obligations
F-36
Table of Contents
F-37
Table of Contents
(in $ millions)
Adjustments
Before
to reduce
After
Application of
Minimum
SFAS No. 158
Application of
SFAS No. 158
Liability
Adjustments
SFAS No. 158
41
(19
)
22
7,914
(19
)
7,895
731
56
787
832
(156
)
213
889
6,995
(156
)
269
7,108
163
137
(269
)
31
919
137
(269
)
787
F-38
Table of Contents
Pension Benefits
Postretirement Benefits
Successor
Successor
As of December 31,
As of December 31,
2006
2005
2006
2005
(In $ millions)
3,407
3,122
377
421
40
40
2
3
183
181
20
23
1
1
18
15
1
(2
)
(1
)
(115
)
163
(14
)
(44
)
128
24
3
1
(1
)
(9
)
(12
)
(205
)
(189
)
(59
)
(63
)
(1
)
(1
)
(1
)
(3
)
32
(24
)
1
1
6
3,343
3,407
343
377
2,603
2,486
332
201
53
44
41
48
1
1
18
15
85
(9
)
(12
)
(205
)
(189
)
(59
)
(63
)
20
(13
)
7
2,802
2,603
(541
)
(804
)
(343
)
(377
)
(1
)
(2
)
(1
)
64
302
(44
)
(31
)
(478
)
(504
)
(388
)
(408
)
(541
)
(660
)
(343
)
(408
)
63
156
(45
)
(478
)
(504
)
(388
)
(408
)
4
(22
)
(38
)
(523
)
(660
)
(305
)
(408
)
(1)
Primarily relates to change in discount rates.
(2)
Amount shown net of tax in the consolidated statements of
shareholders equity. See Note 21 for the related tax
associated with the pension and postretirement benefit
obligations.
F-39
Table of Contents
Pension Benefits
Postretirement Benefits
Successor
Successor
As of December 31,
As of December 31,
2006
2005
2006
2005
5.88
%
5.63
%
5.88
%
5.63
%
4.70
%
4.54
%
4.80
%
4.97
%
5.68
%
5.46
%
5.79
%
5.57
%
4.00
%
4.00
%
4.00
%
4.00
%
3.18
%
3.26
%
3.53
%
3.26
%
3.73
%
3.81
%
3.92
%
3.81
%
Successor
As of December 31,
2006
2005
(In $ millions)
3,264
3,367
3,124
3,204
2,723
2,563
Successor
Predecessor
Successor
Predecessor
Pension Benefits
Postretirement Benefits
Nine Months
Three Months
Nine Months
Three Months
Year Ended
Year Ended
Ended
Ended
Year Ended
Year Ended
Ended
Ended
December 31,
December 31,
December 31,
March 31,
December 31,
December 31,
December 31,
March 31,
2006
2005
2004
2004
2006
2005
2004
2004
(In $ millions)
40
40
30
9
2
3
2
1
183
181
131
40
20
23
19
6
(207
)
(200
)
(131
)
(40
)
1
1
(1
)
(1
)
2
1
2
6
1
2
1
2
(1
)
(1
)
1
4
3
1
3
23
26
39
16
21
25
21
8
Table of Contents
Successor
Predecessor
Successor
Predecessor
Pension Benefits
Postretirement Benefits
Nine Months
Three Months
Nine Months
Three Months
Year Ended
Year Ended
Ended
Ended
Year Ended
Year Ended
Ended
Ended
December 31,
December 31,
December 31,
March 31,
December 31,
December 31,
December 31,
March 31,
2006
2005
2004
2004
2006
2005
2004
2004
(In $ millions)
23
26
39
16
21
25
21
8
(155
)
loss/(gain)
64
117
19
(44
)
(1
)
(1
)
(92
)
117
19
(45
)
(69
)
143
58
16
(24
)
25
21
8
Pension Benefits
Postretirement Benefits
Successor
Successor
As of December 31,
As of December 31,
2006
2005
2006
2005
64
156
(44
)
(1
)
(1
)
63
156
(45
)
(1)
Amount shown net of tax in the consolidated statement of
shareholders equity.
Pension
Postretirement
Benefits
Benefits
1
(2
)
1
(2
)
Table of Contents
Successor
Predecessor
Successor
Predecessor
Pension Benefits
Postretirement Benefits
Nine Months
Three Months
Nine Months
Three Months
Year Ended
Year Ended
Ended
Ended
Year Ended
Year Ended
Ended
Ended
December 31,
December 31,
December 31,
March 31,
December 31,
December 31,
December 31,
March 31,
2006
2005
2004
2004
2006
2005
2004
2004
5.63
%
5.88
%
6.25
%
6.25
%
5.63
%
5.88
%
6.25
%
6.25
%
4.54
%
5.50
%
6.00
%
5.70
%
4.97
%
5.68
%
6.00
%
6.00
%
5.46
%
5.85
%
6.20
%
6.20
%
5.57
%
5.86
%
6.25
%
6.25
%
8.50
%
8.50
%
8.50
%
8.50
%
N/A
N/A
N/A
N/A
6.30
%
6.25
%
7.35
%
7.35
%
N/A
N/A
N/A
N/A
8.17
%
8.19
%
8.40
%
8.40
%
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
4.00
%
4.00
%
4.00
%
4.00
%
N/A
N/A
N/A
N/A
3.26
%
3.25
%
3.25
%
3.25
%
N/A
N/A
N/A
N/A
3.81
%
3.80
%
3.80
%
3.80
%
N/A
N/A
N/A
N/A
F-42
Table of Contents
Weighted
Average
Percentage of
Target
Plan Assets at
Allocation
December 31,
2007
2006
2005
70
%
69
%
77
%
30
%
31
%
22
%
0
%
0
%
1
%
100
%
100
%
Weighted
Average
Percentage of
Target
Plan Assets at
Allocation
December 31,
2007
2006
2005
45
%
50
%
49
%
53
%
49
%
46
%
2
%
1
%
5
%
100
%
100
%
F-43
Table of Contents
Pension
Postretirement
Benefits
Benefits
(In $ millions)
49
38
Postretirement
Benefit
Pension
Expected
Benefit
Federal
Payments(1)
Payments
Subsidy
(In $ millions)
239
38
9
201
35
7
197
32
7
197
30
8
199
36
1,066
154
(1)
Payments are expected to be made primarily from plan assets.
One Percent
One Percent
Increase
Decrease
(In $ millions)
4
(3
)
Successor
As of
As of
December 31,
December 31,
2006
2005
(In $ millions)
40
49
21
9
61
58
F-44
Table of Contents
18.
Environmental
F-45
Table of Contents
Ownership %
Liability %
39.0
%
10.0
%
98.0
%
96.0
%
28.2
%
22.0
%
100.0
%
100.0
%
31.2
%
40.0
%
7.9
%
0.0
%
100.0
%
0.0
%
F-46
Table of Contents
19.
Shareholders
Equity
Preferred
Common
Stock
Stock
(In whole shares)
99,377,884
(99,377,884
)
9,600,000
151,062,161
7,500,000
9,600,000
158,562,161
106,505
9,600,000
158,668,666
F-47
Table of Contents
F-48
Table of Contents
Accumulated
Unrealized
Pension and
Unrealized
Other
Gain (Loss) on
Foreign
Postretirement
Gain/(Loss)
Comprehensive
Marketable
Currency
Benefit
on Derivative
Income
Securities
Translation
Obligation
Contracts
(Loss), Net
(In $ millions)
10
243
(448
)
(3
)
(198
)
7
(46
)
(39
)
17
197
(448
)
(3
)
(237
)
(7
)
7
(19
)
2
(17
)
(7
)
7
(19
)
2
(17
)
3
5
(117
)
(109
)
(4
)
12
(136
)
2
(126
)
13
5
137
2
157
9
17
1
4
31
F-49
Table of Contents
20.
Other
(Charges) Gains, Net
Successor
Predecessor
Nine Months
Three Months
Year Ended
Year Ended
Ended
Ended
December 31,
December 31,
December 31,
March 31,
2006
2005
2004
2004
(In $ millions)
(12
)
(23
)
(8
)
(2
)
1
(4
)
(45
)
3
(11
)
(27
)
(50
)
(2
)
(12
)
5
34
1
(25
)
(32
)
(4
)
(36
)
(1
)
(26
)
(10
)
(66
)
(82
)
(28
)
F-50
Table of Contents
Employee
Termination
Plant/Office
Benefits
Closures
Total
(In $ millions)
72
14
86
(2
)
1
(1
)
27
8
35
(44
)
(9
)
(53
)
(2
)
(2
)
51
14
65
2
2
12
5
17
(37
)
(6
)
(43
)
(6
)
(6
)
28
7
35
F-51
Table of Contents
21.
Income
Taxes
Successor
Predecessor
Nine Months
Three Months
Year Ended
Year Ended
Ended
Ended
December 31,
December 31,
December 31,
March 31,
2006
2005
2004
2004
(In $ millions)
153
(83
)
(106
)
(10
)
183
58
(117
)
14
328
399
43
62
664
374
(180
)
66
51
4
2
(2
)
33
41
19
17
33
55
36
7
117
100
57
22
80
7
2
48
(43
)
(12
)
(5
)
8
(3
)
25
(4
)
136
(39
)
13
(7
)
253
61
70
15
F-52
Table of Contents
Successor
Predecessor
Nine Months
Three Months
Year Ended
Year Ended
Ended
Ended
December 31,
December 31,
December 31,
March 31,
2006
2005
2004
2004
(In $ millions)
232
131
(63
)
27
(3
)
(8
)
115
5
12
10
(2
)
15
10
51
28
12
4
1
(58
)
(104
)
(43
)
(19
)
9
3
2
2
16
10
6
2
9
(5
)
(12
)
4
253
61
70
15
(1)
Includes impact of earnings from Singapore subject to tax
holidays, which expire between 2007 and 2013.
F-53
Table of Contents
Successor
As of
As of
December 31,
December 31,
2006
2005
(In $ millions)
331
393
95
103
270
475
34
11
10
27
740
1,009
(460
)
(710
)
280
299
436
376
26
26
(8
)
8
43
34
497
444
(217
)
(145
)
(1)
Includes deferred tax asset valuation allowances primarily for
the Companys deferred tax assets in the U.S., Mexico,
France and certain Canadian entities, as well as other foreign
jurisdictions. These valuation allowances relate to net
operating loss carryforward benefits and other net deferred tax
assets, all of which may not be realizable.
F-54
Table of Contents
22.
Stock-Based
and Other Management Compensation Plans
F-55
Table of Contents
F-56
Table of Contents
Successor
Year Ended December 31,
2006
2005
5.0
%
4.0
%
7.2
7.5
0.81
%
0.78
%
31.2
%
26.2
%
5.9
%
0.5
%
Year Ended December 31, 2006
Weighted-
Weighted-
Average
Average
Remaining
Aggregate
Number of
Grant
Contractual
Intrinsic
Options
Price in $
Term
Value
(In millions)
(In $ millions)
12
16.15
2
20.87
16.30
(1
)
16.14
13
16.81
7.0
113
8
16.92
7.0
71
7
16.09
6.6
72
F-57
Table of Contents
Year Ended December 31, 2005
Nine Months Ended December 31, 2004
Basic
Diluted
Basic
Diluted
Earnings
Earnings
Earnings (Loss)
Earnings (Loss)
Net
per Common
per Common
Net
per Common
per Common
Earnings
Share
Share
Earnings (Loss)
Share
Share
(In $ millions, except per share information)
267
1.73
1.67
(253
)
(2.55
)
(2.55
)
1
0.01
0.01
(9
)
(0.06
)
(0.05
)
(6
)
(0.06
)
(0.06
)
259
1.68
1.63
(259
)
(2.61
)
(2.61
)
23.
Leases
Capital
Operating
(In $ millions)
5
75
5
70
4
51
4
42
4
33
19
68
(2
)
41
337
16
25
F-58
Table of Contents
24.
Financial
Instruments
F-59
Table of Contents
F-60
Table of Contents
Successor
As of
As of
December 31,
December 31,
2006
2005
Carrying
Fair
Carrying
Fair
Amount
Value
Amount
Value
(In $ millions)
193
193
220
220
265
265
280
280
72
72
75
75
3,189
3,359
3,282
3,452
(37
)
(37
)
(4
)
(4
)
3
3
1
1
(5
)
(5
)
3
3
25.
Commitments
and Contingencies
F-61
Table of Contents
F-62
Table of Contents
F-63
Table of Contents
F-64
Table of Contents
The Company agreed to indemnify Hoechst for environmental
liabilities associated with contamination arising under 19
divestiture agreements entered into by Hoechst prior to the
demerger.
The Company will indemnify Hoechst against those liabilities up
to 250 million;
F-65
Table of Contents
Hoechst will bear those liabilities exceeding
250 million, however the Company will reimburse
Hoechst for one-third of those liabilities for amounts that
exceed 750 million in the aggregate.
F-66
Table of Contents
The Company is secondarily liable under a lease agreement
pursuant to which the Company has assigned a direct obligation
to a third party. The lease assumed by the third party expires
on April 30, 2012. The lease liability for the period from
January 1, 2007 to April 30, 2012 is estimated to be
approximately $41 million.
The Company has agreed to indemnify various insurance carriers,
for amounts not in excess of the settlements received, from
claims made against these carriers subsequent to the settlement.
The aggregate amount of guarantees under these settlements is
approximately $10 million, which is unlimited in term.
F-67
Table of Contents
F-68
Table of Contents
26.
Supplemental
Cash Flow Information
Successor
Predecessor
Nine Months
Three Months
Year Ended
Year Ended
Ended
Ended
December 31,
December 31,
December 31,
March 31,
2006
2005
2004
2004
(In $ millions)
101
65
25
14
239
309
184
48
13
3
(7
)
7
3
5
3
F-69
Table of Contents
27.
Business
and Geographical Segments
Chemical
Acetate
Performance
Total
Other
Products
Products
Ticona
Products
Segments
Activities
Reconciliation
Consolidated
(In $ millions)
4,608
700
915
176
6,399
257
6,656
134
134
(134
)
709
128
201
49
1,087
(423
)
664
155
24
65
15
259
24
283
142
73
27
2
244
8
252
7
(1
)
(6
)
10
10
557
183
429
140
1,309
29
1,338
3,489
711
1,584
361
6,145
1,750
7,895
4,163
659
887
180
5,889
144
6,033
136
136
(136
)
667
71
116
46
900
(526
)
374
167
29
60
13
269
17
286
111
35
54
3
203
9
212
18
9
(8
)
19
47
66
569
218
466
140
1,393
37
1,430
3,280
691
1,583
342
5,896
1,549
7,445
F-70
Table of Contents
Chemical
Acetate
Performance
Total
Other
Products
Products
Ticona
Products
Segments
Activities
Reconciliation
Consolidated
(In $ millions)
2,465
441
636
131
3,673
45
3,718
82
82
(82
)
265
(13
)
26
15
293
(473
)
(180
)
89
30
48
10
177
4
181
59
31
64
3
157
3
160
3
41
37
81
1
82
780
147
227
44
1,198
11
1,209
29
29
(29
)
63
4
45
11
123
(57
)
66
39
11
16
2
68
2
70
15
8
20
43
1
44
1
1
2
26
28
Table of Contents
Successor
Predecessor
As of and for the
As of and for the
For the Nine
For the Three
Year Ended
Year Ended
Months Ended
Months Ended
December 31,
December 31,
December 31,
March 31,
2006
2005
2004
2004
(In $ millions)
2,148
2,046
1,252
413
4,508
3,987
2,466
796
6,656
6,033
3,718
1,209
2,251
1,897
1,256
416
771
696
419
123
535
438
211
66
303
306
221
65
Successor
Predecessor
As of and for the
As of and for the
For the Nine
For the Three
Year Ended
Year Ended
Months Ended
Months Ended
December 31,
December 31,
December 31,
March 31,
2006
2005
2004
2004
(In $ millions)
861
870
1,294
1,161
2,155
2,031
530
480
98
103
149
165
130
97
F-72
Table of Contents
28.
Transactions
and Relationships with Affiliates and Related Parties
Successor
Predecessor
Nine Months
Three Months
Year Ended
Year Ended
Ended
Ended
December 31,
December 31,
December 31,
March 31,
2006
2005
2004
2004
(In $ millions)
274
290
232
77
128
157
135
42
1
1
1
5
3
3
Successor
As of
As of
December 31,
December 31,
2006
2005
(In $ millions)
28
31
41
39
69
70
24
55
182
135
206
190
(1)
Purchases/Sales from/to Affiliates
Purchases and sales from/to Affiliates are accounted for at
prices which, in the opinion of the Company, approximate those
charged to third party customers for similar goods or services.
(2)
Short-term borrowings from Affiliates (See Note 16)
F-73
Table of Contents
29.
Consolidating
Guarantor Financial Information
F-74
Table of Contents
Successor
For the Year Ended December 31, 2006
Parent
Non-
Guarantor
Issuer
Guarantors
Eliminations
Consolidated
(In $ millions)
6,656
6,656
(5,214
)
(5,214
)
1,442
1,442
(6
)
(532
)
(538
)
(66
)
(66
)
(70
)
(70
)
5
5
(15
)
(15
)
(2
)
(2
)
(9
)
(9
)
(6
)
753
747
414
438
86
(852
)
86
(41
)
(253
)
(294
)
37
37
(2
)
90
88
406
397
713
(852
)
664
17
(270
)
(253
)
406
414
443
(852
)
411
(4
)
(4
)
406
414
439
(852
)
407
(1
)
(1
)
406
414
438
(852
)
406
F-75
Table of Contents
Successor
For the Year Ended December 31, 2005
Parent
Non-
Guarantor
Issuer
Guarantors
Eliminations
Consolidated
(In $ millions)
6,033
6,033
(4,731
)
(4,731
)
1,302
1,302
(5
)
(506
)
(511
)
(51
)
(51
)
(91
)
(91
)
34
34
(100
)
(100
)
(10
)
(10
)
(5
)
578
573
278
343
61
(621
)
61
(65
)
(322
)
(387
)
5
33
38
(1
)
90
89
277
278
440
(621
)
374
(61
)
(61
)
277
278
379
(621
)
313
(37
)
(37
)
277
278
342
(621
)
276
1
1
277
278
343
(621
)
277
F-76
Table of Contents
Successor
For the Nine Months Ended December 31, 2004
Parent
Non-
Guarantor
Issuer
Guarantors
Eliminations
Consolidated
(In $ millions)
3,718
3,718
(3,000
)
(3,000
)
718
718
(454
)
(454
)
(43
)
(43
)
(67
)
(67
)
1
1
(83
)
(83
)
(3
)
(3
)
3
3
72
72
(203
)
(71
)
36
274
36
(47
)
(16
)
(239
)
2
(300
)
26
(2
)
24
(3
)
(9
)
(12
)
(253
)
(87
)
(114
)
274
(180
)
(70
)
(70
)
(253
)
(87
)
(184
)
274
(250
)
(8
)
(8
)
(253
)
(87
)
(192
)
274
(258
)
5
5
(253
)
(87
)
(187
)
274
(253
)
F-77
Table of Contents
Predecessor
For the Three Months Ended March 31, 2004
Parent
Non-
Guarantor
Issuer
Guarantors
Eliminations
Consolidated
(In $ millions)
1,209
1,209
(975
)
(975
)
234
234
(136
)
(136
)
(23
)
(23
)
(28
)
(28
)
(1
)
(1
)
46
46
12
12
(6
)
(6
)
5
5
9
9
66
66
(15
)
(15
)
51
51
27
27
78
78
F-78
Table of Contents
F-79
Table of Contents
F-80
Table of Contents
Successor
For the Year Ended December 31, 2006
Parent
Non-
Guarantor
Issuer
Guarantors
Eliminations
Consolidated
(In $ millions)
751
751
(252
)
(252
)
(43
)
(43
)
23
23
(8
)
(8
)
26
26
95
95
(65
)
(65
)
(42
)
(42
)
(2
)
(2
)
(268
)
(268
)
(125
)
(125
)
38
38
13
13
34
34
(68
)
(34
)
(34
)
68
2
2
(36
)
(36
)
(108
)
(108
)
26
26
401
401
1
389
390
1
790
791
F-81
Table of Contents
Successor
For the Year Ended December 31, 2005
Parent
Non-
Guarantor
Issuer
Guarantors
Eliminations
Consolidated
(In $ millions)
9
1
691
701
(212
)
(212
)
(180
)
27
153
(918
)
(918
)
48
48
21
21
75
75
221
221
(149
)
(149
)
7
7
(180
)
27
(907
)
153
(907
)
(804
)
(599
)
(599
)
1,198
(804
)
764
764
233
233
779
572
(1,351
)
(207
)
(1,242
)
(1,449
)
16
16
1,135
1,135
22
22
(31
)
(31
)
(1
)
(8
)
(9
)
(21
)
(21
)
172
(28
)
(135
)
(153
)
(144
)
(98
)
(98
)
1
(449
)
(448
)
838
838
1
389
390
F-82
Table of Contents
Successor
For the Nine Months Ended December 31, 2004
Parent
Non-
Guarantor
Issuers
Guarantors
Eliminations
Consolidated
(In $ millions)
(2
)
(60
)
(62
)
(160
)
(160
)
(1,633
)
(1,633
)
31
31
(1
)
(1
)
132
132
(173
)
(173
)
(6
)
(6
)
(1
)
(1
)
(1,811
)
(1,811
)
641
*
641
(500
)
(500
)
500
(500
)
200
*
200
(221
)
(221
)
(254
)
(254
)
513
1,825
2,338
608
608
18
18
36
29
29
(25
)
(13
)
(167
)
(205
)
227
(227
)
14
14
(1
)
2,687
2,686
3
22
25
838
838
838
838
*
Amounts included in Non-Guarantors column represent proceeds
received directly by the Non-Guarantors, on behalf of the Parent
Guarantor. The legal issuer of the mandatorily redeemable
preferred stock is the Parent Guarantor.
F-83
Table of Contents
Predecessor
For the Three Months Ended March 31, 2004
Parent
Non-
Guarantor
Issuers
Guarantors
Eliminations
Consolidated
(In $ millions)
(102
)
(102
)
(44
)
(44
)
(5
)
(5
)
139
139
42
42
(42
)
(42
)
1
1
91
91
(27
)
(27
)
(16
)
(16
)
(43
)
(43
)
(1
)
(1
)
(55
)
(55
)
148
148
93
93
F-84
Table of Contents
30.
Earnings
(Loss) Per Share
Successor
Year Ended December 31, 2006
Year Ended December 31, 2005
Continuing
Discontinued
Net
Continuing
Discontinued
Net
Operations
Operations
Earnings
Operations
Operations
Earnings
(In $ millions, except for share and per share data)
407
(1
)
406
276
1
277
(10
)
(10
)
(10
)
(10
)
397
(1
)
396
266
1
267
2.51
(0.01
)
2.50
1.72
0.01
1.73
2.37
(0.01
)
2.36
1.66
0.01
1.67
158,597,424
158,597,424
158,597,424
154,402,575
154,402,575
154,402,575
1,205,413
1,205,413
1,205,413
645,655
645,655
645,655
12,004,762
12,004,762
12,004,762
11,151,818
11,151,818
11,151,818
171,807,599
171,807,599
171,807,599
166,200,048
166,200,048
166,200,048
F-85
Table of Contents
Successor
Predecessor
Nine Months Ended December 31, 2004
Three Months Ended March 31, 2004
Continuing
Discontinued
Net
Continuing
Discontinued
Net
Operations
Operations
Earnings (Loss)
Operations
Operations
Earnings
(In $ millions, except for share and per share data)
(258
)
5
(253
)
51
27
78
(258
)
5
(253
)
51
27
78
(2.60
)
0.05
(2.55
)
1.03
0.55
1.58
(2.60
)
0.05
(2.55
)
1.03
0.54
1.57
99,377,884
99,377,884
99,377,884
49,321,468
49,321,468
49,321,468
390,953
390,953
390,953
99,377,884
99,377,884
99,377,884
49,712,421
49,712,421
49,712,421
Table of Contents
F-87
Table of Contents
Exhibit
3
.1
Second Amended and Restated
Certificate of Incorporation (Incorporated by reference to
Exhibit 3.1 to the Current Report on
Form 8-K
filed on January 28, 2005)
3
.2*
Amended and Restated By-laws,
effective as of February 8, 2007
3
.3
Certificate of Designations of
4.25% Convertible Perpetual Preferred Stock (Incorporated
by reference to Exhibit 3.2 to the Current Report on
Form 8-K
filed on January 28, 2005)
4
.1
Form of certificate of
Series A Common Stock (Incorporated by reference to
Exhibit 4.1 to the Registration Statement on
Form S-1
(File
No. 333-120187),
filed on January 13, 2005)
4
.2
Form of certificate of
4.25% Convertible Perpetual Preferred Stock (Incorporated
by reference to Exhibit 4.2 to the Registration Statement
on
Form S-1
(File
No. 333-120187)
filed on January 13, 2005)
4
.3
Indenture, dated as of
June 8, 2004, among BCP Caylux Holdings Luxembourg S.C.A.,
as Issuer, and BCP Crystal Holdings Ltd. 2, as Parent
Guarantor, and The Bank of New York, as Trustee (Incorporated by
reference to Exhibit 10.15 to the Registration Statement on
Form S-1
(File
No. 333-120187)
filed on November 3, 2004)
4
.4
Supplemental Indenture, dated as
of October 5, 2004, among BCP Crystal US Holdings Corp.,
BCP Caylux Holdings Luxembourg S.C.A., BCP Crystal Holdings Ltd.
2 and The Bank of New York, as trustee (Incorporated by
reference to the Exhibit 10.16 to the Registration Statement on
Form
S-1
(File
No. 333-120187
filed) on November 3, 2004)
4
.5
Supplemental Indenture, dated as
of October 5, 2004, among BCP Crystal US Holdings Corp.,
the New Guarantors and The Bank of New York, as trustee
Incorporated by reference to Exhibit 10.17 to the
Registration Statement on the Form
S-1
(File
No. 333-120187)
filed on November 3, 2004)
4
.6
Indenture, dated as of
September 24, 2004, among Crystal US Holdings 3 L.L.C.,
Crystal US Sub 3 Corp., as Issuers, and The Bank of New York, as
Trustee (Incorporated by reference to Exhibit 10.18 to the
Registration Statement on
Form S-1
(File
No. 333-120187)
filed on November 3, 2004)
4
.7
Supplemental Indenture, dated as
of March 30, 2005, among Crystal US Holdings 3 L.L.C.,
Crystal US Sub 3 Corp., Celanese Corporation and The Bank of New
York, as Trustee (Incorporated by reference to
Exhibit 10.15 to the Annual Report on
Form 10-K
filed on March 31, 2005)
4
.8
Amended and Restated Registration
Rights Agreement, dated as of January 26, 2005, by and
among Blackstone Capital Partners (Cayman) Ltd. 1,
Blackstone Capital Partners (Cayman) Ltd. 2, Blackstone
Capital Partners (Cayman) Ltd. 3 and BA Capital Investors
Sidecar Fund, L.P. (Incorporated by reference to
Exhibit 10.2 to the Current Report on
Form 8-K
filed on January 28, 2005)
4
.9
Third Amended and Restated
Shareholders Agreement, dated as of October 31, 2005, by
and among Celanese Corporation, Blackstone Capital Partners
(Cayman) Ltd. 1, Blackstone Capital Partners (Cayman)
Ltd. 2, Blackstone Capital Partners (Cayman) Ltd. 3 and BA
Capital Investors Sidecar Fund, L.P. (Incorporated by reference
to Exhibit 4.3 to the Registration Statement on
Form S-1
(File
No. 333-127902)
filed on November 1, 2005)
4
.10
Amendment No. 1 to the Third
Amended and Restated Shareholders Agreement, dated
November 14, 2005, by and among Celanese Corporation,
Blackstone Capital Partners (Cayman) Ltd. 1, Blackstone
Capital Partners (Cayman) Ltd. 2, Blackstone Capital
Partners (Cayman) Ltd. 3 and BA Capital Investors Sidecar Fund,
L.P. (Incorporated by reference to Exhibit 99.1 to the
Current Report on
Form 8-K
filed on November 18, 2005)
4
.11
Amendment No. 2 to the Third
Amended and Restated Shareholders Agreement, dated
March 30, 2006, by and among Celanese Corporation,
Blackstone Capital Partners (Cayman) Ltd. 1, Blackstone
Capital Partners (Cayman) Ltd. 2, Blackstone Capital
Partners (Cayman) Ltd. 3 and BA Capital Investors Sidecar Fund,
L.P. (Incorporated by reference to Exhibit 4.6 of Annual
Report on
Form 10-K
filed on March 31, 2006.)
Table of Contents
Exhibit
10
.1
Amended and Restated Credit
Agreement, dated as of January 26, 2005, among BCP Crystal
US Holdings Corp., Celanese Holdings LLC, Celanese Americas
Corporation, the lenders thereto, Deutsche Bank AG, New York
Branch, as administrative agent, Deutsche Bank Securities Inc.
and Morgan Stanley Senior Funding, Inc., as joint lead
arrangers, Deutsche Bank Securities Inc., Morgan Stanley Senior
Funding, Inc. and Banc of America Securities LLC, as joint book
runners, Morgan Stanley Senior Funding, Inc., as syndication
agent, and Bank of America, N.A. as documentation agent
(Incorporated by reference to Exhibit 10.1 to Current
Report on
Form 8-K
filed on February 1, 2005)
10
.2
First Amendment to Credit
Agreement, dated as of November 28, 2005, among Celanese
Holdings LLC, BCP Crystal US Holdings Corp., Celanese Americas
Corporation, the lenders from time to time party thereto, and
Deutsche Bank AG, New York Branch, as administrative agent
(Incorporated by reference to Exhibit 10.1 to Current
Report on
Form 8-K
filed on December 2, 2005 )
10
.3
Celanese Corporation 2004 Stock
Incentive Plan (Incorporated by reference to Exhibit 10.7
to the Current Report on
Form 8-K
filed on January 28, 2005)
10
.4
Celanese Corporation Deferred
Compensation Plan (Incorporated by reference to
Exhibit 10.21 to the Registration Statement on
Form S-1
(File
No. 333-120187)
filed on January 3, 2005)
10
.5
Sponsor Services Agreement, dated
as of January 26, 2005, among Celanese Corporation,
Celanese Holdings LLC and Blackstone Management Partners IV
L.L.C. (Incorporated by reference to Exhibit 10.3 to the
Current Report on
Form 8-K
filed on January 28, 2005)
10
.6
Employee Stockholders Agreement,
dated as of January 21, 2005, among Celanese Corporation,
Blackstone Capital Partners (Cayman) Ltd., Blackstone Capital
Partners (Cayman) Ltd. 2, Blackstone Capital Partners
(Cayman) Ltd. 3 and employee stockholders parties thereto from
time to time (Incorporated by reference to Exhibit 10.20 to
the Annual Report of
Form 10-K
filed on March 31, 2005)
10
.7
Form of Nonqualified Stock Option
Agreement (for employees) (Incorporated by reference to
Exhibit 10.5 to the Current Report on
Form 8-K
filed on January 28, 2005)
10
.8
Form of Nonqualified Stock Option
Agreement (for non-employee directors) (Incorporated by
reference to Exhibit 10.6 to the Current Report on
Form 8-K
filed on January 28, 2005)
10
.9
Bonus Plan for fiscal year ended
2005 for named executive officers (Incorporated by reference to
Exhibit 10.24 to the Annual Report of
Form 10-K
filed on March 31, 2005)
10
.10
Employment Agreement, dated as of
February 23, 2005, between David N. Weidman and Celanese
Corporation (Incorporated by reference to Exhibit 10.25 to
the Annual Report of
Form 10-K
filed on March 31, 2005)
10
.11
Bonus Award Letter, dated as of
February 23, 2005, between David N. Weidman and Celanese
Corporation (Incorporated by reference to Exhibit 10.29 to
the Annual Report of
Form 10-K
filed on March 31, 2005)
10
.12
Summary of pension benefits for
David N. Weidman (Incorporated by reference to
Exhibit 10.34 to the Annual Report of
Form 10-K
filed on March 31, 2005)
10
.13
Employment Agreement dated as of
February 17, 2005 between Lyndon B. Cole and Celanese
Corporation (Incorporated by reference to Exhibit 10.26 to
the Annual Report of
Form 10-K
filed on March 31, 2005)
10
.14
Bonus Award Letter, dated as of
February 23, 2005 between Lyndon B. Cole and Celanese
Corporation (Incorporated by reference to Exhibit 10.31 to
the Annual Report of
Form 10-K
filed on March 31, 2005)
10
.15
English Translation of Service
Agreement, dated as of November 1, 2004, between Lyndon B.
Cole and Celanese AG (Incorporated by reference to
Exhibit 10.32 to the Annual Report of
Form 10-K
filed on March 31, 2005)
10
.16
Employment Agreement, dated as of
February 23, 2005, between Andreas Pohlmann and Celanese
Corporation (Incorporated by reference to Exhibit 10.28 to
the Annual Report of
Form 10-K
filed on March 31, 2005)
10
.17
Bonus Award Letter, dated as of
February 23, 2005 between Andreas Pohlmann and Celanese
Corporation (Incorporated by reference to Exhibit 10.30 to
the Annual Report of
Form 10-K
filed on March 31, 2005)
Table of Contents
Exhibit
10
.18
English Translation of Service
Agreement, dated as of November 1, 2004, between Andreas
Pohlmann and Celanese AG (Incorporated by reference to
Exhibit 10.33 to the Annual Report of
Form 10-K
filed on March 31, 2005)
10
.19
Letter of Understanding, dated as
of October 27, 2004, between Andreas Pohlmann and Celanese
Americas Corporation (Incorporated by reference to
Exhibit 10.35 to the Annual Report of
Form 10-K
filed on March 31, 2005)
10
.20
Separation Agreement, dated
June 30, 2006, between Andreas Pohlmann and Celanese
Corporation (Incorporated by reference to Exhibit 10.1 to
Current Report on
Form 8-K
filed on June 30, 2006)
10
.21
Offer letter agreement, effective
April 18, 2005 between Curtis S. Shaw and Celanese
Corporation (Incorporated by reference to Exhibit 10.23 to
the Quarterly Report on
Form 10-Q
filed on May 16, 2005)
10
.22
Employment Agreement, dated as of
August 31, 2005 between John J. Gallagher III and
Celanese Corporation (Incorporated by reference to
Exhibit 10.1 to the Current Report on
Form 8-K
filed on August 31, 2005)
10
.23
Offer letter agreement, effective
as of August 31, 2005 between John J. Gallagher III
and Celanese Corporation (Incorporated by reference to
Exhibit 10.2 to the Current Report on
Form 8-K
filed on August 31, 2005)
10
.24
Nonqualified Stock Option
Agreement, dated as of January 25, 2005, between Celanese
Corporation and Blackstone Management Partners IV L.L.C.
(Incorporated by reference from Exhibit 10.23 to the Annual
Report on
Form 10-K
filed on March 31, 2005)
10
.25
Share Purchase and Transfer
Agreement and Settlement Agreement, dated August 19, 2005
between Celanese Europe Holding GmbH & Co. KG, as
purchaser, and Paulson & Co. Inc., and Arnhold and S.
Bleichroeder Advisers, LLC, each on behalf of its own and with
respect to shares owned by the investment funds and separate
accounts managed by it, as the sellers (Incorporated by
reference to Exhibit 10.1 to the Current Report on
Form 8-K
filed on August 19, 2005)
10
.26
Translation of Letter of Intent,
dated November 29, 2006, among Celanese AG, Ticona GmbH and
Fraport AG (Incorporated by reference to Exhibit 99.2 to
the Current Report on
Form 8-K
filed November 29, 2006)
10
.27*
Purchase Agreement dated as of
December 12, 2006 by and among Celanese Ltd. and certain of
its affiliates named therein and Advent Oxo (Cayman) Limited,
Oxo Titan US Corporation, Drachenfelssee 520. V V GMBH and
Drachenfelssee 521. V V GMBH
12
*
Computation of ratio of earnings
to fixed charges
21
.1*
List of significant subsidiaries
23
.1*
Report on Financial Statement
Schedule and Consent of Independent Registered Public Accounting
Firm, KPMG LLP
23
.2*
Report on Financial Statement
Schedule and Consent of Independent Registered Public Accounting
Firm, KPMG Deutsche Treuhand-Gesellschaft Aktieguesellschaft
Wirtschaflsprufungsgesellschaft
31
.1*
Certification of Chief Executive
Officer pursuant to Section 302 of the Sarbanes-Oxley Act
of 2002
31
.2*
Certification of Chief Financial
Officer pursuant to Section 302 of the Sarbanes-Oxley Act
of 2002
32
.1*
Certification of Chief Executive
Officer pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002
32
.2*
Certification of Chief Financial
Officer pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002
99
.3*
Financial Statement schedule
regarding Valuation and Qualifying Accounts
*
Filed herewith
Portions of this exhibit have been omitted pursuant to a request
for confidential treatment filed with the Securities and
Exchange Commission under
Rule 24b-2
of the Securities Exchange Act of 1934, as amended. The omitted
portions of this exhibit have been separately filed with the
Securities and Exchange Commission.
2
3
4
5
6
7
8
9
10
11
12
13
Page | ||||||||
|
||||||||
1. | Definitions | 2 | ||||||
|
||||||||
2. | Purchase and Sale of Assets | 16 | ||||||
|
||||||||
|
(a) | Purchase of Assets | 16 | |||||
|
||||||||
|
(b) | Excluded Assets | 18 | |||||
|
||||||||
|
(c) | Liabilities | 19 | |||||
|
||||||||
|
(d) | Purchase Price for Purchased Assets | 23 | |||||
|
||||||||
|
(e) | Allocation of Purchase Price | 26 | |||||
|
||||||||
|
(f) | Closing | 26 | |||||
|
||||||||
|
(g) | Deliveries and Actions at Closing | 26 | |||||
|
||||||||
|
(h) | Special Covenants | 27 | |||||
|
||||||||
3. | Representations and Warranties of Parent and Sellers | 28 | ||||||
|
||||||||
|
(a) | Organization | 28 | |||||
|
||||||||
|
(b) | Authorization of Transaction | 28 | |||||
|
||||||||
|
(c) | Non-contravention | 28 | |||||
|
||||||||
|
(d) | Material Contracts | 29 | |||||
|
||||||||
|
(e) | Employee Matters | 30 | |||||
|
||||||||
|
(f) | Litigation | 32 | |||||
|
||||||||
|
(g) | Compliance With Laws | 32 | |||||
|
||||||||
|
(h) | Permits | 33 | |||||
|
||||||||
|
(i) | Environmental Matters | 33 | |||||
|
||||||||
|
(j) | Condemnation | 34 | |||||
|
||||||||
|
(k) | Title to Purchased Assets; Sufficiency | 34 |
i
Page | ||||||||
|
||||||||
|
(l) | Intellectual Property and Technology | 35 | |||||
|
||||||||
|
(m) | Taxes | 36 | |||||
|
||||||||
|
(n) | Capitalization | 38 | |||||
|
||||||||
|
(o) | Financial Information | 39 | |||||
|
||||||||
|
(p) | Inventories | 40 | |||||
|
||||||||
|
(q) | Accounts and Notes Receivable and Payable | 40 | |||||
|
||||||||
|
(r) | Intercompany Transactions | 40 | |||||
|
||||||||
|
(s) | Customers and Suppliers | 40 | |||||
|
||||||||
|
(t) | Product Warranty; Product Liability | 40 | |||||
|
||||||||
|
(u) | Site Service Cost Coverage | 41 | |||||
|
||||||||
|
(v) | Site Service Profit | 41 | |||||
|
||||||||
|
(w) | Disclaimers Regarding Assets | 41 | |||||
|
||||||||
4. | Representations and Warranties of Buyer | 41 | ||||||
|
||||||||
|
(a) | Organization of Buyer | 41 | |||||
|
||||||||
|
(b) | Authorization of Transaction | 42 | |||||
|
||||||||
|
(c) | Non-contravention | 42 | |||||
|
||||||||
|
(d) | Litigation | 42 | |||||
|
||||||||
|
(e) | Availability of Funds; Financing | 42 | |||||
|
||||||||
5. | Pre-Closing Covenants | 43 | ||||||
|
||||||||
|
(a) | General | 43 | |||||
|
||||||||
|
(b) | Notices, Assignments and Consents | 43 | |||||
|
||||||||
|
(c) | Operation of Business | 43 |
ii
Page | ||||||||
|
||||||||
|
(d) | Antitrust Approvals | 45 | |||||
|
||||||||
|
(e) | Access to Information | 46 | |||||
|
||||||||
|
(f) | Cooperation with Financing | 46 | |||||
|
||||||||
|
(g) | Exclusivity | 47 | |||||
|
||||||||
|
(h) | Pensionskasse | 47 | |||||
|
||||||||
|
(i) | Change of Fiscal Year | 47 | |||||
|
||||||||
|
(j) | Amendment of Infraserv Leases | 47 | |||||
|
||||||||
|
(k) | Termination of Hereditary Building Right | 47 | |||||
|
||||||||
|
(l) | Ancillary Shares Consent | 48 | |||||
|
||||||||
6. | Post-Closing Covenants | 48 | ||||||
|
||||||||
|
(a) | General | 48 | |||||
|
||||||||
|
(b) | Employees and European Employees | 48 | |||||
|
||||||||
|
(c) | Noncompetition; Nonsolicitation; Confidentiality | 48 | |||||
|
||||||||
|
(d) | Use of Celanese Name | 51 | |||||
|
||||||||
|
(e) | Taxes; Prorations | 51 | |||||
|
||||||||
|
(f) | Post Closing Cooperation by Buyer | 56 | |||||
|
||||||||
|
(g) | Further Assurances | 57 | |||||
|
||||||||
|
(h) | Notification of Transfer | 57 | |||||
|
||||||||
|
(i) | Special Indemnification | 57 | |||||
|
||||||||
|
(j) | Environmental Matters | 58 | |||||
|
||||||||
|
(k) | Marl Demolitions | 58 | |||||
|
||||||||
|
(l) | License of Retained Intellectual Property | 59 |
iii
Page | ||||||||
|
||||||||
|
(m) | Seller Guarantees | 59 | |||||
|
||||||||
|
(n) | Transaction Services | 60 | |||||
|
||||||||
|
(o) | Oberhausen Hereditary Building Right | 60 | |||||
|
||||||||
7. | Conditions to Obligation to Close | 60 | ||||||
|
||||||||
|
(a) | Conditions to Buyers Obligation | 60 | |||||
|
||||||||
|
(b) | Conditions to Sellers Obligation | 62 | |||||
|
||||||||
8. | Remedies for Breaches of this Agreement | 63 | ||||||
|
||||||||
|
(a) | Survival of Representations and Warranties | 63 | |||||
|
||||||||
|
(b) | Indemnification by Sellers | 64 | |||||
|
||||||||
|
(c) | Indemnification by Buyer | 64 | |||||
|
||||||||
|
(d) | Indemnification Procedures | 64 | |||||
|
||||||||
|
(e) | Limitations | 65 | |||||
|
||||||||
|
(f) | Duty to Mitigate | 66 | |||||
|
||||||||
|
(g) | Exclusive Remedy | 66 | |||||
|
||||||||
9. | Environmental Indemnity | 67 | ||||||
|
||||||||
|
(a) | Indemnification by Sellers | 67 | |||||
|
||||||||
|
(b) | Indemnification by Buyer | 67 | |||||
|
||||||||
|
(c) | Survival | 68 | |||||
|
||||||||
|
(d) | Limitations on Duty to Indemnify | 68 | |||||
|
||||||||
|
(e) | Cost-Sharing | 70 | |||||
|
||||||||
|
(f) | Procedures | 72 | |||||
|
||||||||
|
(g) | Assignment | 73 |
iv
Page | ||||||||
|
||||||||
|
(h) | Exclusive Remedy | 73 | |||||
|
||||||||
10. | Termination | 73 | ||||||
|
||||||||
|
(a) | Termination of Agreement | 73 | |||||
|
||||||||
|
(b) | Effect of Termination | 74 | |||||
|
||||||||
11. | Miscellaneous | 74 | ||||||
|
||||||||
|
(a) | Press Releases and Public Announcements | 74 | |||||
|
||||||||
|
(b) | No Third-Party Beneficiaries | 74 | |||||
|
||||||||
|
(c) | Entire Agreement | 74 | |||||
|
||||||||
|
(d) | Succession and Assignment | 74 | |||||
|
||||||||
|
(e) | Counterparts | 75 | |||||
|
||||||||
|
(f) | Headings | 75 | |||||
|
||||||||
|
(g) | Notices | 75 | |||||
|
||||||||
|
(h) | Governing Law; Arbitration | 76 | |||||
|
||||||||
|
(i) | Amendments and Waivers | 77 | |||||
|
||||||||
|
(j) | Severability | 77 | |||||
|
||||||||
|
(k) | Construction | 77 | |||||
|
||||||||
|
(l) | Incorporation of Exhibits, Annexes, and Schedules | 78 | |||||
|
||||||||
|
(m) | Specific Performance | 78 | |||||
|
||||||||
|
(n) | Limitation on Damages | 78 | |||||
|
||||||||
|
(o) | Bulk Transfer Laws | 79 | |||||
|
||||||||
|
(p) | Parent Guarantee | 79 |
v
Schedule No. | Name of Schedule | |
|
||
1(a) |
Products
|
|
1(b) |
Company Real Property
|
|
1(c) |
Seller Real Property
|
|
1(d) |
Leased Real Property
|
|
1(e) |
Relevant Competition Authority Jurisdictions
|
|
1(f) |
German Contracts
|
|
1(g)-1 |
United States Tangible Personal Property
|
|
1(g)-2 |
German Tangible Personal Property
|
|
1(h) |
German Transferable Permits
|
|
1(i) |
Estech Assets
|
|
2(b) |
Specified Excluded Assets
|
|
2(c)(ii) |
Specified Excluded Liabilities
|
|
2(d)(ii) |
Amounts Subtracted from Working Capital Adjustments
|
|
2(e) |
Purchase Price Allocation
|
|
2(h) |
Pre-Closing IT Separation Tasks
|
|
3(b) |
Required Governmental Approvals
|
|
3(c) |
Required Consents
|
|
3(d) |
Material Contracts
|
|
3(e) |
Employee Matters
|
|
3(f) |
Litigation
|
|
3(g) |
Compliance with Laws
|
|
3(h) |
Material Permits
|
|
3(i) |
Environmental Matters
|
|
3(k) |
Sufficiency of Purchased Assets
|
|
3(l)(i) |
Transferred Intellectual Property
|
|
3(l)(ii) |
Ownership of and Rights to Transferred Technology and Transferred Intellectual Property
|
|
3(l)(iii) |
Infringement Matters
|
|
3(l)(vi) |
Licenses
|
|
3(s) |
Top Customers and Suppliers
|
|
3(t) |
Product Warranty and Liability
|
|
6(b) |
Employee Transfer Procedures
|
|
6(c)(iv) |
Non-Hire Employees
|
|
6(e)(x) |
Broker Commissions
|
|
6(m) |
Seller Guarantees
|
|
6(n) |
Sample Transition Services
|
|
7(a)(ix) |
Material Consents
|
|
7(a)(xiii) |
Intercompany Contracts to Survive
|
vi
Exhibit | Name of Exhibit | |
|
||
A (Section 1)
|
Working Capital Adjustment | |
B (Section 1)
|
Form of Assignment Agreement | |
C (Section 1)
|
Form of Deed (2) | |
D (Section 1)
|
Form of FIRPTA Affidavit | |
E
|
Form of US Site Services Agreements and German Site Services Agreement | |
F-1
|
Form of Formaldehyde Supply Agreement | |
F-2
|
Form of n-Butanol Supply Agreement | |
F-3
|
Form of Acetic Acid Supply Agreement | |
F-4
|
Form of Acetaldehyde Supply Agreement | |
F-5
|
Form of Formalin Supply Agreement | |
F-6
|
Form of Other Products Supply Agreement | |
F-7
|
Form of Ethylene Supply Agreement | |
G
|
Form of Bay City Real Property Lease and Bishop Real Property Lease | |
H
|
Form of Site Closure Agreement | |
I
|
Joint Defense Agreement | |
J
|
Debt Term Sheets | |
K
|
Equity Commitment Letter | |
2(g)(vii)
|
Transfer Deed |
vii
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
For Claims Made: | Sellers Percentage | Buyers Percentage | ||||||
|
||||||||
On or before the First
Anniversary of the Closing
|
100 | % | 0 | % | ||||
|
||||||||
After the First Anniversary of
the Closing but on or before
the Second Anniversary of the Closing
|
93 | % | 7 | % |
70
For Claims Made: | Sellers Percentage | Buyers Percentage | ||||||
|
||||||||
After the Second Anniversary
of the Closing but on or
before the Third Anniversary
of the Closing
|
87 | % | 13 | % | ||||
|
||||||||
After the Third Anniversary of
the Closing but on or before
the Fourth Anniversary of the
Closing
|
80 | % | 20 | % | ||||
|
||||||||
After the Fourth Anniversary
of the Closing but on or
before the Fifth Anniversary
of the Closing
|
73 | % | 27 | % | ||||
|
||||||||
After the Fifth Anniversary of
the Closing but on or before
the Sixth Anniversary of the
Closing
|
67 | % | 33 | % | ||||
|
||||||||
After the Sixth Anniversary of
the Closing but on or before
the Seventh Anniversary of the
Closing
|
60 | % | 40 | % | ||||
|
||||||||
After the Seventh Anniversary
of the Closing but on or
before the Eighth Anniversary
of the Closing
|
53 | % | 47 | % | ||||
|
||||||||
After the Eighth Anniversary
of the Closing but on or
before the Ninth Anniversary
of the Closing
|
47 | % | 53 | % | ||||
|
||||||||
After the Ninth Anniversary of
the Closing but on or before
the Tenth Anniversary of the
Closing
|
40 | % | 60 | % | ||||
|
||||||||
After the Tenth Anniversary of
the Closing but on or before
the Eleventh Anniversary of
the Closing
|
33 | % | 67 | % |
71
For Claims Made: | Sellers Percentage | Buyers Percentage | ||||||
|
||||||||
After the Eleventh Anniversary
of the Closing but on or
before the Twelfth Anniversary
of the Closing
|
27 | % | 73 | % | ||||
|
||||||||
After the Twelfth Anniversary
of the Closing but on or
before the Thirteenth
Anniversary of the Closing
|
20 | % | 80 | % | ||||
|
||||||||
After the Thirteenth
Anniversary of the Closing but
on or before the Fourteenth
Anniversary of the Closing
|
13 | % | 87 | % | ||||
|
||||||||
After the Fourteenth
Anniversary of the Closing but
on or before the Fifteenth
Anniversary of the Closing
|
6 | % | 94 | % | ||||
|
||||||||
After the Fifteenth
Anniversary of the Closing
|
0 | % | 100 | % |
72
73
74
|
If to Parent or Sellers: | Celanese Corporation | ||
|
1601 West LBJ Freeway | |||
|
||||
|
Dallas, TX 75234 | |||
|
Attention: Curtis S. Shaw, Esq., Executive Vice President, General Counsel and Corporate Secretary | |||
|
Fax: (972) 443-4461 | |||
|
||||
|
With copy to: | Thompson Coburn LLP | ||
|
One US Bank Plaza | |||
|
St. Louis, Missouri 63101 | |||
|
Attention: Thomas A. Litz, Esq. | |||
|
Fax: (314) 552-7000 | |||
|
||||
|
If to Buyer: | Advent Oxo (Cayman) Limited | ||
|
75 State Street | |||
|
Boston, Massachusetts 02109 | |||
|
Attention: Janet Henessy | |||
|
Fax: (617) 951-0566 |
75
76
77
78
79
PARENT BUYER:
ADVENT OXO (CAYMAN) LIMITED |
||||
By | /s/ Michael J. Ristaino | |||
Name: | Michael J. Ristaino | |||
Title: | Director | |||
U.S. BUYER:
OXO TITAN US CORPORATION |
||||
By | /s/ Wilhelm Plumpe | |||
Name: | Wilhelm Plumpe | |||
Title: | Managing Director | |||
GERMAN HOLDCO:
DRACHENFELSSEE 520. V V GMBH |
||||
By | /s/ Wilhelm Plumpe | |||
Name: | Wilhelm Plumpe | |||
Title: | Managing Director | |||
GERMAN BUYER:
DRACHENFELSSEE 521. V V GMBH |
||||
By | /s/ Wilhelm Plumpe | |||
Name: | Wilhelm Plumpe | |||
Title: | Managing Director |
U.S. SELLER:
CELANESE LTD. (By its General Partner, Celanese International Corporation) |
PARENT:
For purposes of Sections 3, 6(c) and 11(p) only, CELANESE CORPORATION |
||||||
By | /s/ Jay Townsend | By | /s/ Curtis S. Shaw | ||||
Name: | Jay Townsend | Name: | Curtis S. Shaw | ||||
Title: |
Vice President
|
Title: | Executive Vice President and General Counsel | ||||
TICONA POLYMERS INC.
|
||||
By | /s/ Jay Townsend | |||
Name: | Jay Townsend | |||
Title: | Attorney-In-Fact | |||
GERMAN SELLER:
CELANESE CHEMICALS EUROPE GMBH |
||||
By | /s/ Jay Townsend | |||
Name: | Jay Townsend | |||
Title: | Attorney-In-Fact | |||
By | /s/ Curtis S. Shaw | |||
Name: | Curtis S. Shaw | |||
Title: | Attorney-In-Fact | |||
Successor
Predecessor
Nine Months
Three Months
Ended
Ended
Year Ended December 31,
December 31,
March 31,
Year Ended December 31,
2006
2005
2004
2004
2003
2002
(In $ millions, except ratio of earnings to combined fixed
charges)
664
374
(180
)
66
172
160
(86
)
(61
)
(36
)
(12
)
(35
)
(21
)
109
66
22
16
23
61
3
3
1
2
14
10
350
454
333
16
72
89
1,040
836
140
88
246
299
294
387
300
6
49
55
6
4
4
3
3
6
36
31
21
7
20
28
10
10
4
22
8
350
454
333
16
72
89
3.0
1.8
5.5
3.4
3.4
690
382
(193
)
72
174
210
Jurisdiction
Canada
France
Delaware
Delaware
Germany
Delaware
Canada
Germany
Germany
Germany
Germany
Texas
Singapore
Singapore
Vermont
Delaware
Bermuda
Mexico
Delaware
Germany
Germany
Delaware
/s/ | KPMG Deutsche Treuhand-Gesellschaft Aktiengesellschaft Wirtschaftsprüfungsgesellschaft |
Additions | ||||||||||||||||||||
Charged to
|
Charged to
|
|||||||||||||||||||
Balance at
|
Costs and
|
other
|
Balance at
|
|||||||||||||||||
Beginning of Year | Expenses | Accounts | Deductions | End of Year | ||||||||||||||||
(In $ millions) | ||||||||||||||||||||
Predecessor
|
||||||||||||||||||||
Three Months Ended
March 31, 2004
|
||||||||||||||||||||
Deducted from asset accounts:
|
||||||||||||||||||||
Allowance for Doubtful Accounts
|
22 | 1 | | (1 | )(a) | 22 | ||||||||||||||
Valuation allowance for deferred
tax assets
|
160 | | | | 160 | |||||||||||||||
|
||||||||||||||||||||
Successor
|
||||||||||||||||||||
Nine Months Ended
December 31, 2004
|
||||||||||||||||||||
Deducted from asset accounts:
|
||||||||||||||||||||
Allowance for Doubtful Accounts
|
22 | 4 | | (4 | )(a) | 22 | ||||||||||||||
Valuation allowance for deferred
tax assets
|
160 | 113 | 448 | (b) | (73 | ) | 648 | |||||||||||||
Year Ended December 31,
2005
|
||||||||||||||||||||
Deducted from asset accounts:
|
||||||||||||||||||||
Allowance for Doubtful Accounts
|
22 | 2 | | (8 | )(a) | 16 | ||||||||||||||
Valuation allowance for deferred
tax assets
|
648 | 20 | 73 | (b) | (31 | )(c) | 710 | |||||||||||||
Year Ended December 31,
2006
|
||||||||||||||||||||
Deducted from asset accounts:
|
||||||||||||||||||||
Allowance for Doubtful Accounts
|
16 | 1 | | (1 | )(a) | 16 | ||||||||||||||
Valuation allowance for deferred
tax assets
|
710 | 8 | 1 | (b) | (259 | )(b)(d) | 460 |
(a) | Includes foreign currency translation effects and uncollected accounts written off, net of recoveries | |
(b) | Represents amount charged to goodwill as a result of purchase accounting and Accumulated other comprehensive income (loss), net | |
(c) | Represents reversal of valuation allowance on German deferred tax assets, primarily net operating loss carryforwards | |
(d) | Includes reductions to valuation allowances associated with reductions in net deferred tax assets not resulting in net expense or benefit. |